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Abstract
Linear regression is arguably the most fundamental statistical model; however, the validity
of its use in randomized clinical trials, despite being common practice, has never been crystal
clear, particularly when stratified or covariate-adaptive randomization is used. In this paper,
we investigate several of the most intuitive and commonly used regression models for estimating
and inferring the treatment effect in randomized clinical trials. By allowing the regression
model to be arbitrarily misspecified, we demonstrate that all these regression-based estimators
robustly estimate the treatment effect, albeit with possibly different efficiency. We also propose
consistent non-parametric variance estimators and compare their performances to those of the
model-based variance estimators that are readily available in standard statistical software. Based
on the results and taking into account both theoretical efficiency and practical feasibility, we
make recommendations for the effective use of regression under various scenarios. For equal
allocation, it suffices to use the regression adjustment for the stratum covariates and additional
baseline covariates, if available, with the usual ordinary-least-squares variance estimator. For
unequal allocation, regression with treatment-by-covariate interactions should be used, together
with our proposed variance estimators. These recommendations apply to simple and stratified
randomization, and minimization, among others. We hope this work helps to clarify and promote
the usage of regression in randomized clinical trials.
Key words: ANCOVA; covariate-adaptive randomization; minimization; regression adjust-
ment; stratified randomization.
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1. Introduction
The use of linear regression models is standard practice for estimating the treatment effect in ran-
domized clinical trials, regardless of whether simple randomization, a covariate-adaptive allocation,
or other approaches are used. However, concerns have been raised regarding the validity of the re-
sulting inferences, because the “usual” assumptions for linear regression, such as linearity, normality,
and homoskedasticity, may not be fulfilled, and certainly cannot be verified during the development
of a statistical analysis plan prior to initiation of a trial. Consequently, the use of regression in ran-
domized clinical trials must be justified by demonstrating that valid inference can be obtained even
when the regression model is arbitrarily misspecified. Although this is not the case in general (e.g.,
in observational studies), regression does exhibit the desired robustness thanks to randomization.
The robustness of regression is evident under simple randomization. The seminal work of
Yang and Tsiatis (2001) examined three commonly used regression models, namely, simple regres-
sion, which is equivalent to the difference-in-means estimator, and two regression models that adjust
for covariates with and without covariate-by-treatment interactions. The authors proved that all
three ordinary-least-squares (OLS) estimators are consistent and they argued that the regression
with covariate-by-treatment interactions produces the most efficient estimator. From a practical
standpoint, Wang et al. (2019a) pointed out that the OLS variance estimator is consistent under
equal allocation for regression without interactions, which supports the use of standard statistical
software (e.g., lm in R or proc reg in SAS) for constructing confidence intervals and tests.
Similar results have also been obtained under the “finite population” framework. Freedman
(2008), being apparently unaware of the work by Yang and Tsiatis (2001), criticized regression be-
cause the adjustment (without interactions) can actually reduce the asymptotic precision compared
with that obtained using the difference-in-means estimator. The issue was later addressed in the
influential paper by Lin (2013): the regression with interactions cannot hurt, and often improves,
the asymptotic precision. Lin (2013) also showed that the Huber–White variance estimator is either
consistent or asymptotically conservative.
Compared with simple randomization, the robustness of regression in stratified randomization,
or more generally, covariate-adaptive randomization, appears to be more elusive, despite its exten-
sive use in clinical trials. Covariate-adaptive randomization aims to balance treatment allocation
among covariates. For example, stratified randomization defines a set of strata based on one or more
covariates and performs a separate randomization, most commonly blocked randomization, within
each stratum. Minimization was proposed to achieve balance over covariates margins (Taves, 1974;
Pocock and Simon, 1975). This approach has been generalized for use in simultaneously control-
ling various types of imbalances (within-stratum, within-covariate-margin, and overall) (Hu and Hu,
2012; Hu and Zhang, 2020). For a more comprehensive review, see, for example, Hu et al. (2014)
and Rosenberger and Lachin (2015). The use of covariate-adaptive randomization predominates in
clinical trials. According to a recent survey of 224 randomized trials published in leading medical
journals in 2014, over 80% of them had used covariate-adaptive randomization (Lin et al., 2015).
The past decade has witnessed significant advances in inference under covariate-adaptive random-
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ization. Various valid tests have been proposed using different randomization methods and model as-
sumptions (Shao et al., 2010; Shao and Yu, 2013; Ma et al., 2015, 2020; Wang and Ma, 2020). How-
ever, one drawback of most of these studies is that the data generation model must be correctly
specified. More recently, the topic of robust inference under covariate-adaptive randomization has
drawn much attention (e.g., Bugni et al., 2018, 2019; Ye and Shao, 2018; Wang et al., 2019b). Most
notably, Bugni et al. (2018) studied the two-sample t-test and the regression that adjusts for stratifi-
cation indicators under stratified randomization, without assuming the true data generation model.
Under the finite population framework, Liu and Yang (2019) also proposed a regression-adjusted
treatment effect estimator under stratified randomization that achieves strong balance.
In additional to the stratum covariates, additional baseline covariates may be available to improve
efficiency. However, although the stratification indicators are generally adjusted in the analysis of
clinical trial data as required by regulatory guidelines (ICH E9, 1998; EMA, 2015), the inferential
properties remain largely unknown when additional covariates are adjusted in the regression analysis.
As pointed out in Wang et al. (2019a), “It is an open question, to the best of our knowledge, as to
what happens when more variables than the stratification indicators are included in the ANCOVA
model under such randomization schemes [covariate-adaptive randomization], in terms of consis-
tency of the ANCOVA estimator and how to compute its asymptotic variance under arbitrary model
misspecification.”
Because covariate-adaptive randomization is so common in clinical trials, it is crucial to clarify
and provide guidance on the use of regression models for covariate-adaptive randomized trials, with
the acknowledgment that the models may be misspecified and that additional baseline covariates may
be available. In particular, the following two questions demand definite answers: (i) Which linear
regression model can be used to ensure robust and efficient estimation of the treatment effect? (ii)
Is a consistent variance estimator available and easily accessible to facilitate valid inference?
This paper seeks to address these questions. We evaluate six commonly used regression models for
estimating and inferring treatment effects under a broad range of covariate-adaptive randomizations.
These models cover the scenarios in which only stratum covariates are used for analysis as well as
when additional baseline covariates are also adjusted. Based on the asymptotic results, the most
efficient estimator is identified. Some special cases, such as equal allocation and strong balance, are
discussed in detail. Moreover, we propose non-parametric consistent variance estimators for all of
the regression estimators under consideration. We also examine the OLS variance estimator, which
is commonly used in practice, and indicate when it can be used for valid inference. Finally, we make
practical recommendations for the use of regression under covariate-adaptive randomization.
The rest of the paper is organized as follows. Section 2 introduces the framework and notation for
covariate-adaptive randomization. Section 3 investigates the theoretical properties of three widely
used regression estimators for the treatment effect. Section 4 introduces another three regression
estimators that adjust for additional baseline covariates and investigates their asymptotic properties.
Section 5 studies the optimality of these regression estimators. Section 6 and Section 7 provide the
results of a simulation study and a real data application, respectively. Section 8 presents a short
discussion. All of the proofs are given in the Appendix A.
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2. Framework and notation
Consider a covariate-adaptive randomized experiment with n units. For each unit i = 1, . . . , n,
let Ai denote the treatment assignment with Ai = 1 for the treatment and Ai = 0 for the control, and
Xi denote a p-dimensional vector of baseline covariates. The experimental units are stratified into
K strata based on baseline covariates Xi using a function B: supp(Xi)→ {1, . . . , K}. For example,
the units are stratified according to gender, grade or location. For simplicity, we assume that units
are assigned to each stratum with positive probability, i.e., p[k] = P (Bi = k) > 0, i = 1, . . . , n,
k = 1, . . . , K, where Bi = B(Xi) is the stratum label. In stratum k, let [k] be the index set of units,
let n[k] =
∑
i∈[k] 1, n[k]1 =
∑
i∈[k]Ai, n[k]0 =
∑
i∈[k](1−Ai) denote the number of units, the number of
treated units, and the number of control units, respectively, and let pn[k] = n[k]/n and pi[k] = n[k]1/n[k]
denote the proportions of stratum sizes and the proportions of treated units, respectively. The
theoretical property of covariate-adaptive randomization critically depends on the difference between
the actual treatment assignment and the target treatment proportion pi ∈ (0, 1):
Dn[k] =
n∑
i=1
(Ai − pi)Ii∈[k], k = 1, . . . , K,
where Ii∈[k] is an indicator function which equals one if i ∈ [k] and zero otherwise.
We use the Neyman–Rubin potential outcomes model (Neyman et al., 1990; Rubin, 1974) to
define the treatment effect. For unit i, this model assumes that there are two potential outcomes,
Yi(1) and Yi(0), when exposed to the treatment and to the control, respectively. Under the stable unit
treatment value assumption (Rubin, 1980), the observed outcome Yi is a function of the treatment
assignment and the potential outcomes: Yi = AiYi(1)+(1−Ai)Yi(0). Our goal is to estimate and infer
the treatment effect τ = E{Yi(1)− Yi(0)} based on the observed data {(Yi,Xi, Ai) : i = 1, . . . , n}.
In this paper, we make the following assumptions regarding the data generation process and
covariate-adaptive randomization. We denote the sets of random variables with bounded qth (q ≥
2) moments and positive stratum-specific variances as Lq = {(V1, . . . , Vm) : E(|Vj|q) < ∞, j =
1, . . . , m} and R2 = {(V1, . . . , Vm) : Var{Vj − E(Vj|Bj)} > 0, j = 1, . . . , m}, respectively. Let
A(n) = (A1, . . . , An), B
(n) = (B1, . . . , Bn), and W
(n) = (W1, . . . ,Wn) where Wi = (Yi(1), Yi(0),Xi),
i = 1, . . . , n. We assume that the covariance E[{Xi − E(Xi|Bi)}{Xi − E(Xi|Bi)}T] is (strictly)
positive-definite.
Assumption 1. Wi ∈ L2 ∩ R2, i = 1, . . . , n, are independent and identically distributed (i.i.d.)
samples from the population distribution of W = (Y (1), Y (0),X).
Assumption 2. W (n) ⊥ A(n)|B(n).
Assumption 3.
{{n−1/2Dn[k]}k=1,...,K∣∣B(n)} d−→ N (0,ΣD) a.s., where ΣD = diag{p[k]q[k] : k =
1, . . . , K} with 0 ≤ q[k] ≤ pi(1− pi) for k = 1, . . . , K.
Assumption 4. Dn[k] = Op(
√
n), for k = 1, . . . , K.
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Assumption 2 requires that the treatment assignment be independent of the potential outcomes
and covariates given the stratification. Assumption 3 was proposed by Bugni et al. (2018) to study
inference under covariate-adaptive randomization. This assumption characterizes the asymptotic
behavior of jointly independent imbalances within strata and thus is particularly relevant to stratified
randomization. As simple randomization leads to q[k] = pi(1 − pi), it is reasonable to expect that a
smaller value of qk can be achieved by stratified randomization. For example, when used within each
stratum, Wei’s urn design (Wei, 1978) leads to a qk value between zero and pi(1−pi), whereas blocked
randomization (Zelen, 1974) and Efron’s biased coin design (Efron, 1971) can reduce qk to zero. In the
latter case, we say that the randomization achieves strong balance (Bugni et al., 2018). Moreover,
Assumption 4 is weaker than Assumption 3 as no (asymptotic) independence is required between
different strata, and it allows us to consider the use of a covariate-adaptive randomization method
that has a complicated dependence structure across strata, such as Pocock and Simon’s minimization
(Pocock and Simon, 1975) and the class of designs proposed by Hu and Hu (2012). This assumption
is also satisfied when the asymptotic distribution is not normal, but is instead, for example, is a
truncated normal distribution (Li et al., 2018). We emphasize that Assumption 4 is quite general
and is satisfied by most, if not all, covariate-adaptive randomization methods.
Notation. We need more notations to proceed. For a random variable V , let V˜ = V − E(V |B)
be the V centered at its stratum-specific mean, µV = E(V ) be its mean, and σ
2
V = Var(V ) be its
variance. For potential outcomes ri(a) such as Yi(a) or their transformations (i = 1, . . . , n, a = 0, 1)
and stratum k (k = 1, · · · , K), denote the population mean and the mean within stratum k as
µr(a) = E{ri(a)} and µ[k]r(a) = E{ri(a)|Bi = k}, respectively. The corresponding sample means
for the treatment group are denoted as r¯1 = (1/n1)
∑n
i=1Airi(1) and r¯[k]1 = (1/n[k]1)
∑
i∈[k]Airi(1).
Similarly, we define the population and stratum-specific sample means for the control group as
r¯0 = (1/n0)
∑n
i=1(1 − Ai)ri(0) and r¯[k]0 = (1/n[k]0)
∑
i∈[k](1 − Ai)ri(0). The population and sample
means for the covariates are denoted as µX , µ[k]X, X¯1, X¯[k]1, X¯0, and X¯[k]0. The population variance
of ri(a) is denoted as σ
2
r(a). The asymptotic variances of the treatment effect estimators depend on
the following quantities:
ς2r˜ (pi) =
1
pi
σ2r˜(1) +
1
1− piσ
2
r˜(0), ς
2
Hr =
K∑
k=1
p[k]
[
{µ[k]r(1)− µr(1)} − {µ[k]r(0)− µr(0)}
]2
,
ς2Ar(pi) =
K∑
k=1
p[k]q[k]
{µ[k]r(1)− µr(1)
pi
+
µ[k]r(0)− µr(0)
1− pi
}2
,
ς2pir =
(1− 2pi)2
pi2(1− pi)2
K∑
k=1
p[k]q[k]
[
{µ[k]r(1)− µr(1)} − {µ[k]r(0)− µr(0)}
]2
.
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We denote their sample analog as
ςˆ2r˜ (pi) =
1
pi
K∑
k=1
pn[k]
( 1
n[k]1
∑
i∈[k]
Ai(ri − r¯[k]1)2
)
+
1
1− pi
K∑
k=1
pn[k]
{ 1
n[k]0
∑
i∈[k]
(1− Ai)(ri − r¯[k]0)2
}
,
ςˆ2Hr =
K∑
k=1
pn[k]
{
(r¯[k]1 − r¯1)− (r¯[k]0 − r¯0)
}2
, ςˆ2Ar(pi) =
K∑
k=1
pn[k]q[k]
( r¯[k]1 − r¯1
pi
+
r¯[k]0 − r¯0
1− pi
)2
,
ςˆ2pir =
(1− 2pi)2
pi2(1− pi)2
K∑
k=1
pn[k]q[k]
[
{r¯[k]1 − r¯1} − {r¯[k]0 − r¯0}
]2
.
Let ΣRQ = E[{R−E(R)}{Q− E(Q)}T] be the covariance between two random vectors R and Q.
3. Adjustment for stratum covariates
In this section, we discuss the theoretical properties, i.e., unbiasedness, consistency, asymptotic
normality, and efficiency, of three widely used regression-based point and variance estimators with re-
spect to the treatment effect τ . We do not consider the adjustment of additional covariates Xi, which
is deferred to the next section. In this section, we bring together many pieces scattered through-
out the literature and offer an integrated summary within the linear regression model framework.
To complement the content found in the literature, we consider the validity of the OLS variance
estimator, which is often overlooked but is essential from the practical point of view.
3.1. Difference-in-means
Using the difference in the sample means is perhaps the most straightforward and intuitive ap-
proach for estimating the treatment effect. Unadjusted methods such as this, which also include
the two-sample t-test, are commonly used for analyzing data from randomized clinical trials due
to their simplicity, transparency, and robustness to model-misspecification, among other practical
reasons (Shao et al., 2010; Lin, 2013). Although failure to adjust baseline covariates may reduce the
efficiency and is contrary to regulatory guidelines for analyzing clinical trial data with covariate-
adaptive randomization (ICH E9, 1998; EMA, 2015), we start with the difference-in-means estimator
because of its popularity in practice and its theoretical importance in its own right. It also serves as
a benchmark for evaluating subsequent estimators.
The difference-in-means estimator τˆ = Y¯1 − Y¯0 is equal to the OLS estimator of the coefficient of
Ai in the following regression:
Yi ∼ α + Aiτ.
Let σˆ2 be the usual OLS variance estimator of τˆ . We have the following proposition.
5
Proposition 1. Under Assumptions 1 – 3,
E(τˆ) = τ,
√
n(τˆ − τ) d−→ N (0, ς2
Y˜
(pi) + ς2HY + ς
2
AY (pi)), nσˆ
2 P−→ ς2Y (1− pi),
and the asymptotic variance can be consistently estimated by ςˆ2
Y˜
(pi) + ςˆ2HY + ςˆ
2
AY (pi).
Remark 1. The asymptotic normality of τˆ and the consistent variance estimator were obtained by
Bugni et al. (2018). Proposition 1 complements their results by providing the probability limit of the
usual OLS variance estimator.
By Lemma 1 in the Appendix A, the difference between the limit of the usual OLS estimator and
the true asymptotic variance, ς2Y (1− pi)− {ς2Y˜ (pi) + ς2HY + ς2AY (pi)}, is equal to
ς2Y (1− pi)− ς2Y (pi) +
K∑
k=1
p[k]{pi(1− pi)− q[k]}
{µ[k]Y (1)− µY (1)
pi
+
µ[k]Y (0)− µY (0)
1− pi
}2
.
Thus, generally, the consistency of σˆ2 is not guaranteed, and it is possible that σˆ2 is even anti-
conservative, which could result in an inflated type I error rate. However, an important observation
is that, under simple randomization (where the summation term vanishes), σˆ2 is consistent under
equal allocation (pi = 1/2) or homogeneity (σ2Y (1) = σ
2
Y (0)). This result may support the use of OLS
variance estimator in certain scenarios. Note that, the variance estimator with the assumption of
homoskedasticity is also commonly used, especially for the two-sample t-tests. We do not explore
these estimators as they are not easily fitted into the regression framework; interested readers are
referred to Shao et al. (2010) and Bugni et al. (2018).
Remark 2. The estimator ςˆ2
Y˜
(pi) differs slightly (in terms of the weights pn[k]) from that proposed by
Bugni et al. (2018), but has the same limit. Based on the asymptotic normality and the consistent
variance estimator, we can construct a valid confidence interval or test for the treatment effect τ .
3.2. Regression adjustment without interaction
It is generally recognized that adjusting for baseline covariates can help to remedy the imperfect
balance with respect to the covariates in a completely randomized experiment and thus improve
the precision in estimating the treatment effect (e.g., Cochran, 1957; Cox and Mccullagh, 1982).
Efficiency gain has also been realized both numerically (e.g., Birkett, 1985; Forsythe, 1987) and the-
oretically (e.g., Shao et al., 2010; Ma et al., 2015; Bugni et al., 2018), when the covariates are well
balanced by covariates-adaptive randomization,. As noted in the previous section, regulatory guide-
lines also recommend that the covariates used in the randomization be adjusted in the subsequent
analysis. Given the extensive use of regression models in clinical trials and other randomized com-
parative studies, it is critical to clarify the theoretical properties of the regression-based estimators
under covariate-adaptive randomization. The most basic way to do so is to include the stratification
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indicators in the linear regression model, i.e.,
Yi ∼ α+ Aiτ +
K−1∑
k=1
αkIi∈[k]. (1)
Let τˆadj and σˆ
2
adj be the OLS point and variance estimators of τ and define the following weights
ω[k] =
pi[k](1− pi[k])pn[k]∑K
k′=1 pi[k′](1− pi[k′])pn[k′]
, k = 1, . . . , K.
Denote the stratum-specific treatment effect in stratum k and its difference-in-means estimator as
τ[k] = E{Yi(1)− Yi(0)|Bi = k} = µ[k]Y (1)− µ[k]Y (0), τˆ[k] = Y¯[k]1 − Y¯[k]0.
Proposition 2. The estimator τˆadj has the formula τˆadj =
∑K
k=1 ω[k]τˆ[k]. Under Assumptions 1 – 3,
E(τˆadj) =
K∑
k=1
E[ω[k]]τ[k],
√
n(τˆadj − τ) d−→ N (0, ς2Y˜ (pi) + ς2HY + ς2piY ), nσˆ2adj
P−→ ς2
Y˜
(1− pi) + ς2HY ,
and the asymptotic variance can be consistently estimated by ςˆ2
Y˜
(pi) + ςˆ2HY + ςˆ
2
piY . Furthermore, when
pi = 1/2, the conclusions hold if Assumption 3 is replaced by Assumption 4.
Remark 3. Bugni et al. (2018) obtained the asymptotic normality of τˆadj, the consistent variance
estimator, and the conservativeness of the Huber–White variance estimator under Assumptions 1 –
3. We complement their results by providing the probability limit of the usual OLS variance estimator
widely used in clinical trials. The fact that Assumption 3 can be weakened to Assumption 4, when
pi = 1/2, is also a new result.
The performances of τˆadj and σˆ
2
adj depends on whether the treatment allocation is balanced. For
equal allocation (pi = 1/2), because ς2piY = 0 and ς
2
AY (pi) ≥ 0, the asymptotic variance of τˆadj is less
than or equal to that of τˆ . That is, the regression improves, or at least does not hurt, the precision of
estimating and inferring the treatment effect τ . Moreover, ς2piY = 0 and ς
2
Y˜
(pi) = ς2
Y˜
(1−pi) imply that
σˆ2adj is a consistent estimator for the asymptotic variance of τˆadj. More importantly, Proposition 2
holds under Assumption 4. Thus, for most if not all covariate-adaptive randomized trials, it is valid
and efficient to use the usual OLS point and variance estimators obtained using regression (1). The
validity of the usual OLS point and variance estimators was confirmed by Yang and Tsiatis (2001)
and Wang et al. (2019a), but under simple randomization.
For unequal allocation (pi 6= 1/2), σˆ2adj can be anti-conservative even for a strong balance treatment
assignment, which results in an inflated type I error rate. Even if we use the consistent variance
estimator ςˆ2
Y˜
(pi) + ςˆ2HY + ςˆ
2
piY to construct a valid confidence interval or test, we should keep in mind
that the performance of τˆadj can be worse than that of the difference-in-means estimator.
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3.3. Regression adjustment with interaction
In this section, we study the regression model with stratification-by-treatment interactions un-
der covariate-adaptive randomization. This is motivated in part by results reported in the literature,
which state that adding the interaction terms can further improve precision when estimating the treat-
ment effect under various randomization methods (Yang and Tsiatis, 2001; Lin, 2013; Bugni et al.,
2019; Liu and Yang, 2019).
The third regression under consideration is
Yi ∼ α + Aiτ +
K−1∑
k=1
αkIi∈[k] +
K−1∑
k=1
νkAi(Ii∈[k] − pn[k]). (2)
The OLS estimator of the coefficient of Ai is denoted as τˆinteract. Note that, we center the stratum
indicator Ii∈[k] at its sample mean pn[k] in the interactions to ensure that τˆinteract can be interpreted
as the treatment effect, which is equivalent to the fully saturated regression estimator in Bugni et al.
(2019). In fact, τˆinteract has a more intuitive expression that can be considered to be a stratified
difference-in-means estimator, as shown in the proof of the following Proposition 3:
τˆinteract =
K∑
k=1
pn[k](Y¯[k]1 − Y¯[k]0) =
K∑
k=1
pn[k]τˆ[k], (3)
where τˆ[k] is the difference-in-means estimator for τ[k] in stratum k. As τ =
∑K
k=1 p[k]τ[k], τˆinteract is a
natural plug-in estimator. Let σˆ2interact be the OLS variance estimator of τˆinteract.
Proposition 3. Under Assumptions 1, 2 and 4,
E(τˆinteract) = τ,
√
n(τˆinteract − τ) d−→ N (0, ς2Y˜ (pi) + ς2HY ), nσˆ2interact
P−→ ς2
Y˜
(1− pi),
and the asymptotic variance can be consistently estimated by ςˆ2
Y˜
(pi) + ςˆ2HY .
Remark 4. The asymptotic normality of τˆinteract and the consistent variance estimator were obtained
by Bugni et al. (2019) under a weaker condition, n[k]1/n[k]
P−→ pi, rather than Assumption 4. We use
Assumption 4 for two reasons: first, it is satisfied by almost all covariate-adaptive randomizations,
and second, we require Assumption 4 to obtain the validity of the regression without interactions
methods discussed in Section 3.2 and Section 4.2 for the case of equal allocation.
Based on the asymptotic normality and using the consistent variance estimator, we can construct
a valid confidence interval or test for τ . Moreover, Proposition 3 implies that the OLS variance
estimator σˆ2interact can be anti-conservative even when pi = 1/2, so we should not use it. As in many
clinical trials, pi = 1/2, so we discuss this special case in more details.
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Corollary 1. When pi = 1/2, under Assumptions 1, 2 and 4, τˆinteract and τˆadj are asymptotically
equivalent, with both asymptotic variances being smaller than or equal to that of τˆ . Furthermore,
both nσˆ2adj and ςˆ
2
Y˜
(pi) + ςˆ2HY are consistent variance estimators.
Corollary 1 implies that for almost all covariate-adaptive randomization with equal allocation, it
is valid and efficient to use regression (2) to estimate and infer τ .
3.4. Summary and recommendation
Table 1: Summary of asymptotic results for various regression-based treatment effect estimators.
Regression Target Proposed consistent Is OLS variance
adjustment allocation Estimator Asymptotic variance variance estimator estimator valid?
Stratification 1/2 τˆ ς2
Y˜
(pi) + ς2HY + ς
2
AY (pi) ςˆ
2
Y˜
(pi) + ςˆ2HY + ςˆ
2
AY (pi) No
only τˆadj ς
2
Y˜
(pi) + ς2HY ςˆ
2
Y˜
(pi) + ςˆ2HY Yes
τˆinteract ς
2
Y˜
(pi) + ς2HY ςˆ
2
Y˜
(pi) + ςˆ2HY No
6= 1/2 τˆ ς2
Y˜
(pi) + ς2HY + ς
2
AY (pi) ςˆ
2
Y˜
(pi) + ςˆ2HY + ςˆ
2
AY (pi) No
τˆadj ς
2
Y˜
(pi) + ς2HY + ς
2
piY ςˆ
2
Y˜
(pi) + ςˆ2HY + ςˆ
2
piY No
τˆinteract ς
2
Y˜
(pi) + ς2HY ςˆ
2
Y˜
(pi) + ςˆ2HY No
Stratification 1/2 τˆ ∗ ς2r˜ (pi) + ς
2
Hr + ς
2
Ar(pi) ςˆ
2
r˜ (pi) + ςˆ
2
Hr + ςˆ
2
Ar(pi) No
and τˆ ∗adj ς
2
r˜adj
(pi) + ς2Hradj ςˆ
2
r˜es(pi) + ςˆ
2
Hres Yes
additional τˆ ∗interact ς
2
r˜interact
(pi) + ς2Hrinteract ςˆ
2
r˜es2(pi) + ςˆ
2
Hres2
No
covariates 6= 1/2 τˆ ∗ ς2r˜ (pi) + ς2Hr + ς2Ar(pi) ςˆ2r˜ (pi) + ςˆ2Hr + ςˆ2Ar(pi) No
τˆ ∗adj ς
2
r˜adj
(pi) + ς2Hradj + ς
2
piradj
ςˆ2r˜es(pi) + ςˆ
2
Hres + ςˆ
2
pires No
τˆ ∗interact ς
2
r˜interact
(pi) + ς2Hrinteract ςˆ
2
r˜es2
(pi) + ςˆ2Hres2 No
Note: All listed estimators are consistent and asymptotically normal.
Table 2: Recommendation for regression-based treatment effect estimators.
Regression adjustment Target allocation Point estimator Variance estimator
Stratification only 1/2 τˆadj σˆ
2
adj
6= 1/2 τˆinteract {ςˆ2Y˜ (pi) + ςˆ2HY }/n
Stratification and 1/2 τˆ∗adj σˆ
2∗
adj
additional covariates 6= 1/2 τˆ∗interact {ςˆ2r˜es2(pi) + ςˆ2Hres2}/n
The asymptotic variances and variance estimators of τˆ , τˆadj, and τˆinteract are summarized in Ta-
ble 1. As ς2AY (pi) and ς
2
piY are non-decreasing functions of q[k], τˆ and τˆadj under covariate-adaptive
randomization are always no worse than those obtained under simple randomization. Thus, covariate-
adaptive randomization can improve efficiency compared to simple randomization, even when adjust-
ing for stratification indicators in the analysis. Generally, the asymptotic variances of τˆ and τˆadj are
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not ordered unambiguously when pi 6= 1/2. Moreover, as ς2piY ≥ 0 and ς2AY (pi) ≥ 0, the strati-
fied difference-in-means estimator τˆinteract has the smallest asymptotic variance. When pi = 1/2, it
holds that ς2piY = 0, thus τˆadj and τˆinteract are asymptotically equivalent, both being no worse than
τˆ . Furthermore, when the treatment assignment achieves strong balance (q[k] = 0, k = 1, . . . , K),
ς2AY (pi) = ς
2
piY = 0, which implies that τˆ , τˆadj and τˆinteract are asymptotically equivalent. Taking into
account both simplicity and efficiency, our recommendations are summarized in Table 2. Note that,
the asymptotic variances of τˆinteract and, when pi = 1/2, τˆadj do not depend on a particular covariate-
adaptive randomization procedure as long as the randomization satisfies Assumption 4. Thus, the
recommendations apply for most commonly used covariate-adaptive randomization methods, includ-
ing stratified randomization and minimization.
4. Adjustment for additional baseline covariates
Apart from the stratification indicators, the covariates Xi may contain additional information
with which to better estimate the treatment effect. Regression adjustment is a common strategy
for adjusting for additional covariates to improve the precision (Liu and Yang, 2019; Li and Ding,
2020). In the following, we discuss three widely used regression methods that adjust for additional
covariates, which correspond to the three regressions discussed in Section 3 with the addition of
Xi. Note that if a discrete covariate has already been adjusted in the regression as a stratification
indicator, it is not, per se, an additional covariate. In general, we should remove the covariates that
can be linearly represented by the stratification indicators from Xi. For simplicity, however, we
continue to use the same notation. Before formally stating the asymptotic results, we define several
population-level regression (or projection) coefficients: for a = 0, 1,
γ(a) = argmin
γ∈Rp
E
[
Yi(a)− E{Yi(a)} − {Xi − E(Xi)}Tγ
]2
= Σ−1
XX
ΣXY (a),
β(a) = argmin
β∈Rp
E
[
Yi(a)− E{Yi(a)|Bi} − {Xi − E(Xi|Bi)}Tβ
]2
= Σ−1
X˜X˜
Σ
X˜Y (a),
where γ(a) is the population regression coefficient for regressing Yi(a) on Xi with an intercept,
and β(a) is the population regression coefficient for regressing Y˜i(a) (= Yi(a)− E{Yi(a)|Bi}) on X˜i
(= Xi − E(Xi|Bi)).
4.1. Difference-in-means
First, we consider the regression method that regresses Yi on Ai and Xi with an intercept but
without stratification indicators:
Yi ∼ α + Aiτ +XTi γ. (4)
Because making no adjustment to the stratum covariates is contrary to regulatory guidelines and
general practice, and usually decreases efficiency (which becomes more evident shortly), we only
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include just a short discussion for completeness. Denote τˆ ∗ as the OLS point estimator of τ in
regression (4), and define the transformed outcomes ri(a) = Yi(a) −XTi γ, where γ = piγ(1) + (1 −
pi)γ(0). We have the following theorem.
Theorem 1. Suppose that (ri(1), ri(0)) ∈ R2 and Assumptions 1 – 3 hold, then
√
n(τˆ ∗ − τ) d−→ N (0, ς2r˜ (pi) + ς2Hr + ς2Ar(pi)).
Furthermore, the difference between the asymptotic variances of τˆ ∗ and τˆ is
∆∗−diff = − 1
pi(1− pi) ×
[
γTΣXXγ − 2(2pi − 1)γTΣXX{γ(1)− γ(0)}+
γT
K∑
k=1
p[k]
{
1− q[k]
pi(1− pi)
}
(µ[k]X − µX)(µ[k]X − µX)Tγ −
2γT
K∑
k=1
p[k]
{
1− q[k]
pi(1− pi)
}
(µ[k]X − µX){(1− pi)(µ[k]Y (1)− µY (1)) + pi(µ[k]Y (0)− µY (0))}
]
.
Remark 5. Similar to τˆ , the first two terms of the asymptotic variance of τˆ ∗ are irrelevant to
q[k], whereas the third term increases with q[k]. Thus, the covariate-adaptive randomization with
0 ≤ q[k] < pi(1 − pi) is always no worse than simple randomization (q[k] = pi(1 − pi)) if we use
regression (4) under both randomization procedures.
Remark 6. For simple randomization with equal allocation (pi = 1/2), ∆∗−diff = −γTΣXXγ/{pi(1−
pi)} ≤ 0. Thus, τˆ ∗ is generally more efficient than τˆ , which reproduces the results in Yang and Tsiatis
(2001). For general covariate-adaptive randomization with 0 ≤ q[k] < pi(1 − pi), τˆ ∗ may hurt the
precision even when pi = 1/2, as compared with τˆ . Later, we show that adding stratification indicators
(when pi = 1/2) or adding both stratification indicators and treatment-by-covariate interactions (when
pi 6= 1/2) generally improves efficiency, so we do not recommend τˆ ∗.
4.2. Regression adjustment without interaction
The second most widely used regression analysis method that adjusts for additional covariates
Xi in randomized experiments including clinical trials is to regresses Yi on Ai, Ii∈[k] and Xi:
Yi ∼ α+ Aiτ +
K−1∑
k=1
αkIi∈[k] +X
T
i β. (5)
We refer to this regression method as analysis of covariance (ANCOVA). Let τˆ ∗adj and σˆ
2∗
adj be the
OLS point and variance estimators of τ , respectively, and let βˆadj be the OLS estimator of β. Define
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the transformed outcomes ri,adj(a) = Yi(a)−XTi βadj, where βadj = piβ(1) + (1− pi)β(0), and denote
the residuals ri,es(a) = Yi(a)−XTi βˆadj.
Theorem 2. Suppose that (ri,adj(1), ri,adj(0)) ∈ R2 and Assumptions 1 – 3 hold, then
√
n(τˆ ∗adj − τ) d−→ N (0, ς2r˜adj(pi) + ς2Hradj + ς2piradj), nσˆ2∗adj
P−→ ς2r˜adj(1− pi) + ς2Hradj ,
the asymptotic variance can be consistently estimated by ςˆ2r˜es(pi) + ςˆ
2
Hres
+ ςˆ2pires, and the difference
between the asymptotic variances of τˆ ∗adj and τˆadj is
∆adj∗−adj = − 1
pi(1− pi)β
T
adjΣX˜X˜βadj +
2(2pi − 1)
pi(1− pi) β
T
adjΣX˜X˜{β(1)− β(0)}.
Furthermore, when pi = 1/2, the conclusions hold if Assumption 3 is replaced by Assumption 4.
Based on the above results, we can compare the efficiencies of different estimators. First, we
consider the case of equal allocation (pi = 1/2). In this case, ∆adj∗−adj = −βTadjΣX˜X˜βadj/{pi(1−pi)} ≤
0, thus, the asymptotic variance of τˆ ∗adj is no greater than that of τˆadj. In Corollary 1 we showed that
τˆadj and τˆinteract are asymptotically equivalent and they are more efficient than (or at least as efficient
as) τˆ . Therefore, τˆ ∗adj is more efficient than (or at least as efficient as) τˆ , τˆadj, and τˆinteract. Later,
we show later that in general, τˆ ∗adj is also more efficient than τˆ
∗ (see the following Corollary 2 and
Theorem 4). Moreover, as ς2piradj = 0 and ς
2
r˜adj
(1−pi) = ς2r˜adj(pi), the usual OLS variance estimator σˆ2∗adj
is consistent. Therefore, it is valid to infer τ based on the result obtained from standard statistical
packages that perform regression (5).
However, for unequal allocation (pi 6= 1/2), τˆ ∗adj may hurt the precision when compared with that
of τˆadj, and σˆ
2∗
adj can be anti-conservative. The same phenomenon has been observed when estimating
the sample average treatment effect in completely randomized experiments under the finite population
framework (Freedman, 2008).
4.3. Regression adjustment with interaction
In this section, we consider a regression that follows the same principle as that described in Section
3.3 while adding additional covariates Xi:
Yi ∼ α + Aiτ +
K−1∑
k=1
αkIi∈[k] +
K−1∑
k=1
νkAi(Ii∈[k] − pn[k]) +XTi β + Ai(Xi − X¯)Tξ. (6)
Denote τˆ ∗interact and σˆ
2∗
interact as the OLS point and variance estimators of τ , respectively. Note that we
center the stratification indicators and covariates at their sample means in the interactions to ensure
that τ can be interpreted as the treatment effect. As shown in our proof, regression (6) is equivalent to
running two regressions. First, we separately regress the outcomes Yi on the stratification indicators
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Ii∈[k] and covariates Xi in the treatment and control groups, and obtain the OLS estimators βˆ(1)
and βˆ(0) of the coefficients of Xi. Then:
τˆ ∗interact =
K∑
k=1
pn[k]
[{
Y¯[k]1 − (X¯[k]1 − X¯[k])Tβˆ(1)
}
−
{
Y¯[k]0 − (X¯[k]0 − X¯[k])Tβˆ(0)
}]
.
Remark 7. By comparing the above expression to (3), τˆ ∗interact can be viewed as augmenting τˆinteract
by further adjusting for the additional covariates Xi when estimating the stratum-specific treatment
effect. This covariate adjustment has also been used for estimators under simple or stratified ran-
domization (Tsiatis et al., 2008; Liu and Yang, 2019).
Define the transformed outcomes ri,interact(a) = Yi(a)−XTi βinteract and residuals ri,es2(a) = Yi(a)−
X
T
i βˆinteract, where βinteract = (1− pi)β(1) + piβ(0) and βˆinteract = (1− pi[k])βˆ(1) + pi[k]βˆ(0).
Theorem 3. Suppose that (ri,interact(1), ri,interact(0)) ∈ R2 and Assumptions 1, 2 and 4 hold, then
√
n(τˆ ∗interact − τ) d−→ N (0, ς2r˜interact(pi) + ς2Hrinteract),
nσˆ2∗interact
P−→ ς2r˜interact(1− pi)−
{ 1
pi(1− pi) − 3
}
{β(1)− β(0)}TΣ
X˜X˜
{β(1)− β(0)},
and the asymptotic variance can be consistently estimated by ςˆ2r˜es2(pi) + ςˆ
2
Hres2
. Furthermore, the
difference of the asymptotic variances of τˆ ∗interact and τˆinteract is
∆interact∗−interact = − 1
pi(1− pi)β
T
interactΣX˜X˜βinteract ≤ 0,
and the difference between the asymptotic variances of τˆ ∗interact and τˆ
∗
adj is
∆interact∗−adj∗ = − 1
pi(1 − pi)(βinteract − βadj)
TΣ
X˜X˜
(βinteract − βadj)T − ς2piradj ≤ 0.
Remark 8. Theorem 3 still holds if we replace Assumption 4 by an even weaker condition pi[k]
P−→ pi;
however, we still use Assumption 4 in the theorem for the same reason as stated in Remark 4.
Theorem 3 implies that the regression with treatment-by-covariate interactions results in an es-
timator τˆ ∗interact whose asymptotic variance is no greater than that of τˆinteract, the most efficient
estimator among τˆ , τˆadj, and τˆinteract. That is, using additional covariates in an interaction regression
will improve, or at least not hurt, the efficiency. As ∆interact∗−adj∗ ≤ 0, the regression with treatment-
by-covariate interactions is generally more efficient than ANCOVA. As 1/{pi(1 − pi)} − 3 ≥ 1, the
OLS variance estimator σˆ2∗interact may underestimate the asymptotic variance even when pi = 1/2 and
thus should not be used. Theorem 3 provides a consistent variance estimator that can be used to
construct a valid confidence interval or test for τ . We note that the asymptotic variance of τˆ ∗interact
and the proposed variance estimator are invariant with respect to randomization methods.
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Corollary 2. When pi = 1/2, under Assumptions 1, 2, and 4, τˆ ∗adj and τˆ
∗
interact are asymptotically
equivalent and their asymptotic variances are smaller than or equal to that of τˆinteract. Furthermore,
both nσˆ2∗adj and ςˆ
2
r˜es2
(pi) + ςˆ2Hres2 are consistent variance estimators.
Corollary 2 implies that, when pi = 1/2, τˆ ∗adj is as efficient as τˆ
∗
interact, neither of which hurts the
efficiency, as compared with τˆ , τˆadj, and τˆinteract, and it is valid and efficient to use the OLS point
and variance estimators in ANCOVA. For equal allocation, we recommend the ANCOVA for two
reasons: first, it has significantly fewer parameters than the regression with treatment-by-covariate
interactions, and second, it is easily implemented by standard statistical packages.
4.4. Summary and recommendation
At the end of this section, we present a summary of the asymptotic variances and variance
estimators in Table 1, which provides answers to the open question raised by Wang et al. (2019a)
(stated in the introduction). Based on the above arguments, when taking into account both simplicity
and efficiency, Table 2 shows our recommendations for regression estimators that adjust for additional
covariates Xi. As in Section 3.4, these recommendations apply to most of the widely used covariate-
adaptive randomization methods, including stratified randomization and minimization.
5. S-optimal
In this section, we will show that τˆ ∗interact is optimal among the following class of estimators:
S , {τˆ ∗(ηˆ(1), ηˆ(0)), τˆ ∗adj(ηˆ(1), ηˆ(0)), τˆ ∗interact(ηˆ(1), ηˆ(0))},
where ηˆ(1) and ηˆ(0) are some adjusted vectors and
τˆ ∗(ηˆ(1), ηˆ(0)) = {Y¯1 − (X¯1 − X¯)Tηˆ(1)} − {Y¯0 − (X¯0 − X¯)Tηˆ(0)},
τˆ ∗adj(ηˆ(1), ηˆ(0)) =
K∑
k=1
ω[k]
[{Y¯[k]1 − (X¯[k]1 − X¯[k])Tηˆ(1)} − {Y¯[k]0 − (X¯[k]0 − X¯[k])Tηˆ(0)}],
τˆ ∗interact(ηˆ(1), ηˆ(0)) =
K∑
k=1
pn[k]
[{Y¯[k]1 − (X¯[k]1 − X¯[k])Tηˆ(1)} − {Y¯[k]0 − (X¯[k]0 − X¯[k])Tηˆ(0)}].
Definition 1. Given the randomization mechanism, τˆ ∗interact is S-optimal if it has the smallest asymp-
totic variance among the estimators in S.
The definition of the S-optimal estimator appeared in Li and Ding (2020) for completely ran-
domized experiments, which we extend to covariate-adaptive randomization. In additional to τˆ ∗,
τˆ ∗adj, and τˆ
∗
interact, S contains other regression estimators, such as those with added interactions
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Ai(Xi − X¯) in regression (4) or deleted interactions Ai(Xi − X¯) from regression (6). Our next
theorem shows that τˆ ∗interact is S-optimal, so those regressions need not be investigated. Define
ri,gen(a) = Yi(a)−XTi {(1− pi)η(1) + piη(0)}, a = 0, 1.
Theorem 4. Suppose that Assumptions 1 – 3 hold, ηˆ(1)
P−→ η(1), ηˆ(0) P−→ η(0), and (ri,gen(1), ri,gen(0)) ∈
R2, then, τˆ ∗interact is S-optimal.
Remark 9. We note that τˆ ∗interact is not optimal among all regression adjusted estimators for at
least two reasons. First, there exists weights ω˜[k] such that
∑K
k=1 ω˜[k][{Y¯[k]1 − X¯T[k]1βˆ(1)} − {Y¯[k]0 −
X¯
T
[k]0βˆ(0)}] has a smaller asymptotic variance than τˆ ∗interact. However, these weights ω˜[k] depend on
the unknown potential outcomes in a complicated form. We leave to future work the investigation
of semi-parametric efficiency under covariate-adaptive randomization. Second, to further improve
efficiency, we can use the stratum-specific adjusted vectors βˆ[k](1) and βˆ[k](0) within stratum k instead
of the common adjusted vectors βˆ(1) and βˆ(0) for all strata. Equivalently, the use of higher-order
interactions, such as AiIi∈[k]Xi, can further improve efficiency in theory; however, evidence suggested
that this may lead to inferior performance when there exists small strata (Liu and Yang, 2019).
6. Simulation Study
In this section, we report the results of a simulation study in which the empirical performances of
the six proposed estimators were examined with respect to treatment effect estimation and asymptotic
variance. For comparison, the typical OLS and Huber–White variance estimators are also considered.
For a ∈ {0, 1} and 1 ≤ i ≤ n, the potential outcomes are generated using the equation: Yi(a) =
µa+ga(Xi)+σa(Xi)εa,i, where Xi, ga(Xi), and σa(Xi) are specified below for three different models.
In each of the models, (Xi, ε0,i, ε1,i), 1 ≤ i ≤ n are i.i.d, and both ε0,i and ε1,i follow the standard
normal distribution. The number of units n is 1000.
Model 1 (Linear model): Xi is a five-dimensional vector,
g0(Xi) = g1(Xi) =
5∑
j=1
βjXij,
where Xi1 ∼ Beta(2, 2), Xi2 takes values in {1, 2, 3, 4} with equal probability, Xi3 ∼ Unif[−2, 2], Xi4
takes values in {1, 2, 3} with respective probabilities of 0.3, 0.6, 0.1 and Xi5 ∼ N (0, 1), and they are
all independent of each other. σ0(Xi) = 1, σ1(Xi) = 3, β = (2, 8, 10, 3, 6)
T. Xi2 and Xi4 are used
for randomization, and Xi1 and Xi3 are used as the additional covariates.
Model 2 (Non-linear model with additional information): Xi is a four-dimensional vector,
g0(Xi) = α1Xi1 + log(α3Xi1 log(Xi3 + 1) + 1) + α4e
Xi4 ,
g1(Xi) = α2X
2
i2 + log(α3Xi1 log(Xi3 + 1) + 1),
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where Xi1 ∼ Gamma(2, 1), Xi2 takes values in {1, 2, 3} with respective probabilities of 0.3, 0.6, 0.1,
Xi3 ∼ Poisson(3), Xi4 ∼ Beta(2, 2), and they are all independent of each other. σ0(Xi) =
2, σ1(Xi) = 1, α = (5, 10, 3, 20)
T. Xi1 and Xi2 are used for randomization, and the stratum of
Xi1 is determined by its relative value of 2.5. Xi1 and Xi3 are used as the additional covariates.
Model 3 (Non-linear model with dependent covariates and errors): Xi is a four-dimensional vector,
g0(Xi) =
4∑
j=1
βjXij,
g1(Xi) = β1 log(Xi1)Xi4,
where Xi1 ∼ Beta(3, 4), Xi2 ∼ Unif[−2, 2], Xi3 = Xi1Xi2, Xi4 takes values in {3, 5} with respective
probabilities of 0.6, 0.4. Xi1, Xi2, Xi4 are independent of each other. σ0(Xi) = Xi3S, σ1(Xi) = 2Xi2S,
and β = (20, 7, 5, 6)T, where Xi2S is the stratified variable of Xi2, if Xi2 > 1, Xi2S = 2, and Xi2S = 1
otherwise, and Xi3S is the stratified variable of Xi3, if Xi3 > 0, Xi3S = 2, and Xi3S = 1 otherwise.
Xi2S and Xi4 are used for randomization, Xi1 and Xi3 are used as the additional covariates.
Here we present the simulation results of the six estimators under simple randomization, the strat-
ified block randomization (Zelen, 1974), and Pocock and Simon’s minimization (Pocock and Simon,
1975) in Table 3 (equal allocation) and Table 4 (unequal allocation). The block size used in the strat-
ified block randomization was 6. The biased-coin probability and the weight used in the Pocock and
Simon’s minimization were 0.75 and (0.5, 0.5)T, respectively. The bias, standard deviation (SD) of
the treatment effect estimators, standard error (SE) estimators, and empirical coverage probabilities
(CP) were computed using 104 replications. For bias calculation, the true treatment effect is defined
as µ1 − µ0 + E{g1(Xi)} − E{g0(Xi)} and was evaluated numerically by integration. Note that,
under Pocock and Simon’s minimization, the standard error estimators of τˆinteract and τˆ
∗
interact, and
when pi = 1/2, τˆadj and τˆ
∗
adj, are calculated according to the known theory, but they are not available
for other estimators. Additional simulation results under biased-coin design (Efron, 1971), adaptive
biased-coin design (Wei, 1978), and the randomization method proposed by Hu and Hu (2012) can
be found in the Appendix B.
Table 3 presents the simulation results under equal allocation. First, we can see that the six
treatment effect estimators all have small finite-sample biases. Under simple randomization, the
standard deviations of τˆadj and τˆinteract are comparable and smaller than that of τˆ , with the reduction
varying from approximately 3% to 28% for different models. Regarding stratified block random-
ization, which achieves strong balance, the standard deviations of these three estimators are nearly
the same, which is consistent with the theoretical results. Under Pocock and Simon’s minimization,
the first three estimators also tend to have similar standard deviations. Moreover, by adding the
stratification indicators into the regression, almost identical standard deviations are obtained by the
different randomization methods, regardless of whether the interaction terms are included.
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Table 3: Simulated biases, standard deviations, standard errors, and coverage probabilities for dif-
ferent estimators and randomization methods under equal allocation (pi = 1/2).
Simple Randomization Stratified Block Randomization Minimization
Bias SD SE CP Bias SD SE CP Bias SD SE CP
Model Estimator NEW OLS HW NEW OLS HW NEW OLS HW NEW OLS HW NEW OLS HW NEW OLS HW
1 τˆ -0.04 1.01 1.01 1.02 1.01 0.95 0.95 0.95 0.00 0.83 0.83 1.02 1.01 0.95 0.99 0.99 -0.01 0.85 - 1.02 1.01 - 0.97 0.97
τˆadj -0.02 0.83 0.83 0.84 0.83 0.95 0.95 0.95 0.01 0.83 0.83 0.84 0.83 0.95 0.95 0.95 -0.00 0.85 0.83 0.84 0.83 0.94 0.94 0.94
τˆinteract -0.02 0.83 0.83 0.84 0.83 0.95 0.95 0.95 0.01 0.83 0.83 0.84 0.83 0.95 0.95 0.95 -0.00 0.85 0.83 0.84 0.83 0.94 0.95 0.94
τˆ ∗ -0.01 0.73 0.70 0.71 0.70 0.95 0.95 0.95 -0.01 0.39 0.40 0.71 0.70 0.95 1.00 1.00 -0.01 0.42 - 0.71 0.70 - 1.00 1.00
τˆ ∗adj 0.01 0.42 0.40 0.41 0.40 0.95 0.95 0.95 -0.00 0.39 0.40 0.41 0.40 0.95 0.95 0.95 -0.01 0.42 0.40 0.41 0.40 0.94 0.94 0.94
τˆ ∗interact 0.01 0.42 0.40 0.41 0.40 0.95 0.95 0.94 -0.00 0.39 0.40 0.41 0.40 0.95 0.95 0.95 -0.00 0.42 0.40 0.41 0.40 0.94 0.94 0.94
2 τˆ 0.01 1.13 1.12 1.12 1.12 0.94 0.94 0.94 -0.03 0.85 0.84 1.12 1.12 0.94 0.99 0.99 -0.05 0.86 - 1.12 1.12 - 0.98 0.98
τˆadj -0.02 0.84 0.84 0.84 0.85 0.95 0.95 0.95 0.01 0.85 0.84 0.84 0.84 0.94 0.94 0.94 -0.07 0.86 0.84 0.84 0.84 0.95 0.95 0.95
τˆinteract 0.03 0.82 0.84 0.41 0.41 0.95 0.67 0.66 0.01 0.85 0.84 0.41 0.41 0.94 0.66 0.65 -0.04 0.86 0.84 0.41 0.41 0.95 0.64 0.64
τˆ ∗ 0.02 1.11 1.09 1.09 1.09 0.94 0.94 0.94 -0.01 0.84 0.82 1.08 1.09 0.94 0.99 0.99 -0.03 0.85 - 1.09 1.09 - 0.99 0.99
τˆ ∗adj -0.01 0.83 0.82 0.82 0.83 0.95 0.95 0.95 0.03 0.83 0.82 0.83 0.82 0.94 0.94 0.94 -0.05 0.85 0.82 0.83 0.83 0.95 0.95 0.95
τˆ ∗interact 0.02 0.81 0.82 0.35 0.35 0.95 0.60 0.59 0.02 0.83 0.82 0.35 0.35 0.94 0.60 0.60 -0.04 0.84 0.82 0.35 0.35 0.95 0.59 0.59
3 τˆ 0.00 1.99 2.00 2.00 2.00 0.95 0.95 0.95 -0.03 1.92 1.94 2.00 2.00 0.95 0.96 0.96 -0.07 1.81 - 2.00 2.00 - 0.96 0.96
τˆadj 0.03 1.91 1.94 1.95 1.95 0.96 0.96 0.96 -0.03 1.92 1.94 1.94 1.94 0.95 0.95 0.95 -0.06 1.81 1.94 1.94 1.94 0.96 0.96 0.96
τˆinteract -0.01 1.91 1.94 1.77 1.76 0.96 0.93 0.93 -0.03 1.92 1.94 1.76 1.76 0.95 0.92 0.92 -0.08 1.81 1.94 1.76 1.76 0.96 0.93 0.93
τˆ ∗ -0.05 1.58 1.54 1.55 1.55 0.95 0.95 0.95 -0.02 1.45 1.48 1.54 1.54 0.96 0.97 0.97 -0.00 1.44 - 1.55 1.54 - 0.96 0.96
τˆ ∗adj -0.02 1.52 1.49 1.49 1.50 0.95 0.95 0.95 -0.02 1.45 1.48 1.49 1.49 0.96 0.96 0.96 0.01 1.44 1.49 1.49 1.49 0.95 0.95 0.95
τˆ ∗interact -0.04 1.50 1.49 0.70 0.70 0.95 0.62 0.62 0.01 1.45 1.48 0.70 0.69 0.96 0.64 0.64 0.02 1.44 1.49 0.70 0.70 0.95 0.66 0.65
Note: SD, standard deviation; SE, standard error; CP, coverage probability; HW, the
Huber–White variance estimator; NEW: the proposed non-parametric variance estimator.
Making use of additional covariates in the regression can further improve the precision when
estimating the treatment effect, as shown in Table 3. More precisely, compared with the standard
deviations of τˆinteract, the standard deviations of τˆ
∗
interact are 1.22% − 51.81% smaller under simple
randomization, and 2.38% − 51.81% smaller under stratified block randomization and Pocock and
Simon’s minimization. Note that the relationship among the last three estimators is the same as that
among the first three estimators.
Table 3 also confirms that the proposed variance estimators coincide with the simulated variance
of the treatment effect estimators and lead to the expected 95% coverage probability. Moreover, the
OLS and Huber–White variance estimators are valid for τˆadj and τˆ
∗
adj, so in this situation, we can
rely on the output of standard statistical packages, such as lm in R package stat, to obtain a valid
inference. The OLS and Huber–White variance estimators are also valid for Model 1, but the model
assumptions are very strong and may not be satisfied in practice. For other scenarios, however, the
OLS and Huber–White variance estimators are generally not valid and can be either larger or smaller
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than the true values. In particular, both the variance estimators tend to be anti-conservative for
τˆinteract, which concurs with the results of Bugni et al. (2019).
Table 4 shows the simulation results under unequal allocation (pi = 2/3). Our findings can be
summarized as follows. First, both τˆadj and τˆ
∗
adj appear to have larger biases, whereas the biases of the
other four estimators are negligible. Second, unlike equal allocation, adjustment of the stratification
indicators does not guarantee a gain in efficiency when the stratification-by-treatment interactions are
not included; the standard deviation of τˆadj is larger than that of τˆ under model 3. However, adding
the interactions always reduces the standard deviation. For example, under simple randomization,
the standard deviations of τˆinteract are 2.22%−40.97% and 1.14%−18.27% smaller than those of τˆ and
τˆadj, respectively. Similar conclusions can be drawn for the last three estimators. Third, adjusting
for additional covariates can further improve the efficiency. Among the six estimators, τˆ ∗interact is the
most efficient, and its variance is invariant under different randomization methods, which reflects the
benefit of adding treatment-by-covariate interactions under unequal allocation. Finally, the OLS and
Huber–White variance estimators of τˆinteract or τˆ
∗
interact are no longer similar, and they are not valid
under most of the considered scenarios. In extreme cases, the coverage probability when using the
OLS variance estimator is as small as 0.10. The proposed variance estimators, in contrast, are still
valid and lead to the expected 95% coverage probability under all scenarios.
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Table 4: Simulated biases, standard deviations, standard errors, and coverage probabilities for dif-
ferent estimators and randomization methods under unequal allocation (pi = 2/3).
Simple Randomization Stratified Block Randomization Minimization
Bias SD SE CP Bias SD SE CP Bias SD SE CP
Model Estimator NEW OLS HW NEW OLS HW NEW OLS HW NEW OLS HW NEW OLS HW NEW OLS HW
1 τˆ 0.01 1.08 1.07 1.08 1.07 0.95 0.96 0.95 -0.05 0.89 0.87 1.07 1.07 0.95 0.98 0.98 -0.05 0.86 - 1.08 1.07 - 0.99 0.99
τˆadj 0.01 0.91 0.88 0.90 0.88 0.93 0.94 0.94 -0.03 0.89 0.87 0.88 0.87 0.95 0.95 0.95 -0.05 0.84 - 0.89 0.88 - 0.96 0.96
τˆinteract 0.01 0.91 0.87 0.90 0.88 0.94 0.94 0.94 -0.03 0.89 0.87 0.88 0.86 0.95 0.95 0.95 -0.05 0.85 0.87 0.89 0.87 0.96 0.96 0.96
τˆ ∗ -0.01 0.74 0.74 0.75 0.74 0.95 0.96 0.95 -0.03 0.43 0.42 0.75 0.74 0.95 1.00 1.00 0.00 0.43 - 0.75 0.74 - 1.00 1.00
τˆ ∗adj -0.00 0.42 0.42 0.44 0.42 0.95 0.96 0.95 -0.02 0.42 0.42 0.43 0.42 0.95 0.96 0.95 0.01 0.41 - 0.44 0.42 - 0.97 0.96
τˆ ∗interact -0.00 0.42 0.42 0.44 0.42 0.95 0.96 0.95 -0.02 0.43 0.42 0.43 0.41 0.95 0.96 0.94 0.01 0.41 0.42 0.44 0.42 0.96 0.97 0.96
2 τˆ -0.01 1.04 1.06 1.30 1.06 0.95 0.98 0.95 -0.11 0.89 0.89 1.29 1.06 0.94 0.99 0.98 -0.07 0.92 - 1.30 1.05 - 1.00 0.98
τˆadj -0.09 1.00 1.02 0.81 1.03 0.96 0.88 0.96 0.03 0.89 0.89 0.82 1.02 0.95 0.94 0.97 -0.01 0.92 - 0.82 1.02 - 0.92 0.97
τˆinteract -0.02 0.85 0.88 0.36 0.50 0.96 0.59 0.75 -0.02 0.89 0.89 0.36 0.49 0.95 0.59 0.72 -0.01 0.91 0.88 0.36 0.49 0.95 0.56 0.71
τˆ ∗ 0.00 0.98 1.01 1.29 1.01 0.95 0.99 0.95 -0.09 0.88 0.86 1.28 1.01 0.95 0.99 0.97 -0.05 0.89 - 1.28 1.01 - 1.00 0.97
τˆ ∗adj -0.08 0.98 1.01 0.80 1.01 0.95 0.90 0.95 0.03 0.87 0.86 0.81 1.00 0.95 0.93 0.98 0.00 0.90 - 0.81 1.00 - 0.92 0.97
τˆ ∗interact -0.02 0.82 0.86 0.31 0.43 0.95 0.53 0.69 -0.02 0.87 0.86 0.31 0.42 0.95 0.52 0.67 -0.01 0.88 0.86 0.31 0.43 0.94 0.52 0.67
3 τˆ -0.01 1.86 1.80 2.40 1.80 0.95 0.99 0.95 -0.04 1.75 1.76 2.39 1.80 0.95 0.99 0.95 -0.00 1.76 - 2.39 1.80 - 0.99 0.96
τˆadj 0.06 1.94 1.85 2.30 1.86 0.94 0.98 0.94 -0.04 1.75 1.76 2.28 1.85 0.95 0.98 0.96 0.02 1.76 - 2.28 1.85 - 0.99 0.97
τˆinteract -0.01 1.82 1.76 2.15 1.56 0.94 0.98 0.92 -0.01 1.75 1.76 2.13 1.56 0.95 0.98 0.92 0.02 1.75 1.75 2.13 1.56 0.96 0.98 0.92
τˆ ∗ -0.02 1.63 1.64 1.72 1.64 0.96 0.97 0.96 -0.05 1.61 1.62 1.71 1.64 0.95 0.96 0.95 -0.04 1.64 - 1.71 1.64 - 0.96 0.95
τˆ ∗adj 0.07 1.75 1.72 1.57 1.73 0.95 0.92 0.95 -0.08 1.61 1.62 1.56 1.71 0.95 0.95 0.96 -0.03 1.64 - 1.56 1.72 - 0.93 0.96
τˆ ∗interact 0.01 1.48 1.45 0.85 0.62 0.95 0.74 0.57 -0.01 1.46 1.45 0.84 0.62 0.95 0.73 0.59 0.02 1.45 1.45 0.85 0.62 0.95 0.75 0.59
Note: SD, standard deviation; SE, standard error; CP, coverage probability; HW, the
Huber–White variance estimator; NEW: the proposed non-parametric variance estimator.
7. Clinical Trial Example
In this section, we consider a clinical trial example based on the synthetic data of the Nefazodone
CBASP trial, which was conducted to compare the efficacy of three treatments for chronic depression
(Keller et al., 2000). We focus on two of the treatments, Nefazodone and the combination of Nefa-
zodone and the cognitive behavioral-analysis system of psychotherapy (CBASP). The process used
to generate the synthetic data is detailed in the Appendix C. The analysis was performed according
to the recommendations given in Table 2, and the results are shown in Table 5.
As seen in Table 5, for simple randomization, adjusting for stratification indicators and additional
baseline covariates clearly improves the estimation precision. Compared with τˆ , the variance reduc-
tions for τˆadj and τˆ
∗
adj are about 5% and 8%, respectively, under equal allocation, and the reductions
for τˆinteract and τˆ
∗
interact are more significant under unequal allocation, i.e., approximately 7% and
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12%, respectively. With respect to stratified block randomization, which achieves strong balance, the
variance reduction of τˆadj under equal allocation is close to 0 and that of τˆinteract under unequal allo-
cation is exactly 0, as expected. Moreover, the variance reductions of τˆ ∗adj and τˆ
∗
interact are moderate,
approximately 2.50% and 6% under equal allocation and unequal allocation, respectively. Finally,
we note that the performance of each of the recommended estimators is comparable for different
randomization methods.
Table 5: Estimates, 95% confidence intervals, and variance reductions under simple randomization
and stratified block randomization for synthetic Nefazodone CBASP trial data.
Randomization Equal Allocation (pi = 1/2) Unequal Allocation (pi = 2/3)
Methods Estimator Estimate 95% CI Variance Reduction Estimator Estimate 95% CI Variance Reduction
Simple τˆ -4.69 (-5.68, -3.70) — τˆ -4.70 (-5.75, -3.65) —
Randomization τˆadj -4.69 (-5.66, -3.72) 4.97% τˆinteract -4.70 (-5.71, -3.68) 6.69%
τˆ ∗adj -4.70 (-5.65, -3.74) 7.99% τˆ
∗
interact -4.70 (-5.69, -3.72) 12.48%
Stratified τˆ -4.69 (-5.65, -3.73) — τˆ -4.69 (-5.71, -3.67) —
Block τˆadj -4.69 (-5.66, -3.73) -0.81% τˆinteract -4.69 (-5.71, -3.67) 0%
Randomization τˆ ∗adj -4.69 (-5.64, -3.74) 2.50% τˆ
∗
interact -4.69 (-5.68, -3.70) 6.15%
Note: CI, confidence interval.
8. Discussion
Linear regression is widely used to analyze the results of randomized clinical trials and other
experiments with the hope of improving efficiency. In this article, we investigated the theoretical
properties of six widely used regression-based treatment effect estimators under covariate-adaptive
randomization, without imposing any modeling assumptions on the potential outcomes and covari-
ates. We showed that these estimators are all consistent and asymptotically normal, albeit with
possibly different efficiency. We provided non-parametric variance estimators to construct a valid
confidence interval or test for the treatment effect and discussed the conditions under which the
usual OLS variance estimator is valid.
Taking into account both simplicity and efficiency, our final recommendations to practitioners
are as follows. For equal allocation, we recommend using regression (without interactions), which
adjusts for the stratification indicators and additional covariates if available, and the use of the usual
OLS variance estimator. For unequal allocation, we recommend using regression with interactions
and the proposed non-parametric variance estimator.
This paper focused on using linear regression to estimate and infer the treatment effect under
covariate-adaptive randomization with two treatments. It would be interesting to extend the results
to more complicated settings, such as linear regression analysis for multiple treatments, for binary
outcomes using logistic regression, and when there are missing values. Moreover, in this paper, we
assumed that the number of strata and the number of covariates were fixed. It would be of interest
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to generalize the results to high-dimensional settings. Finally, although our results provide insights
for using more general classes of models, theoretical results have yet to be established, especially
regarding semi-parametric efficiency, which merits further investigation.
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A. Proof of main results
A.1. Useful lemmas
We first introduce some useful lemmas obtained from Bugni et al. (2018, 2019). Several additional
lemmas will be given later.
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Lemma 1. For any potential (transformed) outcomes ri(a), i = 1, . . . , n, a = 0, 1,
ς2r˜ (pi) + ς
2
Hr + ς
2
Ar(pi) = ς
2
r (pi)−
K∑
k=1
p[k]{pi(1− pi)− q[k]}
{µ[k]r(1)− µr(1)
pi
+
µ[k]r(0)− µr(0)
1− pi
}2
.
Lemma 2. Suppose that Assumptions 1, 2 and 4 hold, then, for i.i.d. random variables Vi, i =
1, . . . , n, satisfying E(|Vi|) <∞, we have
1
n
n∑
i=1
AiVi
P−→ piE(V1).
Lemma 3. Under Assumptions 1, 2 and 4, we have
n1
n
P−→ pi, n[k]1
n[k]
P−→ pi, n[k]1
n
P−→ pip[k], pn[k] =
n[k]
n
P−→ p[k],
n0
n
P−→ 1− pi, n[k]0
n[k]
P−→ 1− pi, n[k]0
n
P−→ pip[k].
Lemma 1 can be found in the proof of Theorem 1 of Bugni et al. (2018). Lemma 2 is a special
case of Lemma C.4 of Bugni et al. (2019). Lemma 3 can be obtained directly from Lemma 2 and the
strong low of large numbers. We omit the proofs of these lemmas.
A.2. Proof of Proposition 1
Proof. The asymptotic normality of τˆ and the consistency of the non-parametric variance estimator
have been proved by Bugni et al. (2018), so we omit it. We will only prove the unbiasedness and
the probability limit of the variance estimator σˆ2. We first compute the conditional expectation
E{Y¯1|B(n), A(n)}.
E{Y¯1|B(n), A(n)} = 1
n1
n∑
i=1
AiE{Yi(1)|B(n), A(n)}
=
1
n1
n∑
i=1
AiE{Yi(1)|B(n)}
= E{Yi(1)|B(n)} 1
n1
n∑
i=1
Ai
= E{Yi(1)|Bi},
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where the second equality is because of Assumption 2 that W (n) ⊥ A(n)|B(n), and the last equality
is because Wi = (Yi(1), Yi(0),Xi) are i.i.d. and (1/n1)
∑n
i=1Ai = 1. Similarly,
E{Y¯0|B(n), A(n)} = E{Yi(0)|Bi}.
Thus,
E(τˆ ) = E(Y¯1 − Y¯0) = E[E{Yi(1)|Bi} − E{Yi(0)|Bi}] = E{Yi(1)− Yi(0)} = τ.
Next, we obtain the probability limit of σˆ2. Let Zdiff be the n× 2 design matrix with the ith row
(Ai, 1). By the property of OLS, nσˆ
2 is the (1,1) element of the following matrix(
1
n− 2
n∑
i=1
rˆ2i
)(
1
n
Z
T
diffZdiff
)
−1
,
where rˆi are the residuals. By Lemma 3, we have(
1
n
Z
T
diffZdiff
)
−1
=
[
n1/n n1/n
n1/n 1
]
−1
P−→ 1
pi(1− pi)
[
1 −pi
−pi pi
]
. (7)
The residuals rˆi will not change if we run the following regression:
Yi ∼ Aiτ1 + (1− Ai)τ0.
By the property of OLS, it holds that
1
n− 2
n∑
i=1
rˆ2i =
1
n− 2
n∑
i=1
Ai(Yi − Y¯1)2 + 1
n− 2
n∑
i=1
(1− Ai)(Yi − Y¯0)2 = n1 − 1
n− 2 σˆ
2
Y (1) +
n0 − 1
n− 2 σˆ
2
Y (0),
where
σˆ2Y (1) =
1
n1 − 1
n∑
i=1
Ai(Yi − Y¯1)2, σˆ2Y (0) =
1
n0 − 1
n∑
i=1
(1− Ai)(Yi − Y¯0)2.
By Lemmas 2 and 3 (see also the proof of Theorem 4.1 of Bugni et al. (2018)),
σˆ2Y (a)
P−→ σ2Y (a), a = 0, 1.
Therefore,
1
n− 2
n∑
i=1
rˆ2i
P−→ piσ2Y (1) + (1− pi)σ2Y (0). (8)
Combing (7) and (8),
nσˆ2
P−→ σ
2
Y (1)
1− pi +
σ2Y (0)
pi
= ς2Y (1− pi).
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A.3. Proof of Proposition 2
Proof. The formula and asymptotic normality of τˆadj, and the consistency of the non-parametric
variance estimator have been obtained in Bugni et al. (2018); see Theorem 4.3 and Theorem 4.4.
Note that, by carefully examining the proof of these two theorems, when pi = 1/2, the third term in
the asymptotic variance (ς2piY ) requiring the asymptotically independent normal distribution of Dn[k]
vanishes, and the conclusions hold if we replace Assumption 3 by the weaker Assumption 4. In the
following, we will calculate the bias of τˆadj and investigate the property of the usual OLS variance
estimator under Assumptions 1, 2 and 4.
We first compute the conditional expectation E{Y¯[k]1|B(n), A(n)}.
E{Y¯[k]1|B(n), A(n)} = 1
n[k]1
n∑
i=1
AiE{Yi(1)Ii∈[k]|B(n), A(n)}
=
1
n[k]1
n∑
i=1
AiIi∈[k]E{Yi(1)|B(n)}
=
1
n[k]1
n∑
i=1
AiIi∈[k]E{Yi(1)|Bi}
=
1
n[k]1
n∑
i=1
AiIi∈[k]E{Yi(1)|Bi = k}
= E{Yi(1)|Bi = k}, (9)
where the second equality is because of Assumption 2 that W (n) ⊥ A(n)|B(n), the third equality is
because Wi = (Yi(1), Yi(0),Xi) are i.i.d., and the last equality is due to (1/n[k]1)
∑n
i=1AiIi∈[k] = 1.
Similarly,
E{Y¯[k]0|B(n), A(n)} = E{Yi(0)|Bi = k}.
Thus,
E{Y¯[k]1 − Y¯[k]0|B(n), A(n)} = τ[k].
Therefore
E(τˆadj) =
K∑
k=1
E
{
ω[k]E(Y¯[k]1 − Y¯[k]0|B(n), A(n))
}
=
K∑
k=1
E(ω[k])τ[k].
Next, we prove the asymptotic property of σˆ2adj. Regression (1) is equivalent to the following regres-
sion:
Yi ∼ τAi +
K∑
k=1
αkIi∈[k].
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The l2 loss function of the OLS is
n∑
i=1
(Yi − τAi −
K∑
k=1
αkIi∈[k])
2 =
K∑
k=1
∑
i∈[k]
(Yi − τAi − αk)2.
The OLS estimator τˆadj, αˆ1,adj, . . . , αˆK,adj has the following formula:
τˆadj =
K∑
k=1
ω[k](Y¯[k]1 − Y¯[k]0), αˆk,adj = Y¯[k] − pi[k], k = 1, . . . , K.
Let rˆi,adj and Zadj be the residuals and the n× (K + 1) design matrix of regression (1), respectively.
Lemma 4. Under Assumptions 1, 2 and 4,
1
n
n∑
i=1
rˆ2i,adj
P−→ pi(1− pi){ς2
Y˜
(1− pi) + ς2HY },
1
n
Z
T
adjZadj
P−→ Σadj,
where
Σ−1adj =


1
pi(1−pi)
− 1
1−pi
− 1
1−pi
· · · − 1
1−pi
− 1
1−pi
pi
1−pi
+ 1
p[1]
pi
1−pi
· · · pi
1−pi
− 1
1−pi
...
. . .
...
...
...
. . .
...
− 1
1−pi
pi
1−pi
· · · · · · pi
1−pi
+ 1
p[K]


.
The proof of Lemma 4 can be found in the proof of Lemma B.9 in Bugni et al. (2018) (requiring
minor modification when replacing Assumption 3 by Assumption 4), so we omit it. By Lemma 4,
nσˆ2adj converges in probability to
ς2
Y˜
(1− pi) + ς2HY .
A.4. Proof of Proposition 3
Proof. We first prove the equivalence of the stratified difference-in-means estimator and the OLS
estimator in the interactive regression (2). The OLS estimator of the coefficient of Ai in regression (2)
does not change if we run the following regression:
Yi ∼ τAi +
K∑
k=1
αkIi∈[k] +
K∑
k=1
βkAi[Ii∈[k] − pn[k]].
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The l2 loss function of the above regression is
K∑
k=1
∑
i∈[k]
{
Yi − αk −
(
τ + βk −
K∑
k=1
βkpn[k]
)
Ai
}2
. (10)
By the property of OLS, the solution should satisfy
τˆinteract + βˆk −
K∑
k=1
βˆkpn[k] = τˆ[k].
Taking average weighted by pn[k], we have
τˆinteract =
K∑
k=1
pn[k]τˆ[k].
Second, we prove the unbiasedness. In the proof of Proposition 2, we have shown in (9) that
E{Y¯[k]1|B(n), A(n)} = E{Yi(1)|Bi = k}, E{Y¯[k]0|B(n), A(n)} = E{Yi(0)|Bi = k}.
Thus,
E{Y¯[k]1 − Y¯[k]0|B(n), A(n)} = τ[k].
Since E(pn[k]) = p[k] and
∑K
k=1 p[k]τ[k] = τ , therefore,
E(τˆinteract) = E
{ K∑
k=1
pn[k](Y¯[k]1 − Y¯[k]0)
}
=
K∑
k=1
E(pn[k])τ[k] =
K∑
k=1
p[k]τ[k] = τ.
Third, the asymptotic normality of τˆinteract is a special case of Theorem 3.1 in Bugni et al. (2019),
so we omit the proof.
Finally, we derive the probability limit of the OLS variance estimator σˆ2interact. By (10), the
residual within stratum k is
rˆi,interact = Yi − Y¯[k] − τˆ[k](Ai − pi[k]),
which is the residual of regressing Yi on Ai within stratum k. Applying Lemma 4 within stratum k,
we have
1
n[k]
∑
i∈[k]
rˆ2i,interact
P−→ pi(1− pi)
(
E[{Yi(1)− µ[k]Y (1)}2|Bi = k]
1− pi +
E[{Yi(0)− µ[k]Y (0)}2|Bi = k]
pi
)
.
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Since n[k]/n
P−→ p[k], then,
1
n
n∑
i=1
rˆ2i,interact =
K∑
k=1
n[k]
n
1
n[k]
∑
i∈[k]
rˆ2i,interact
P−→ pi(1− pi)ς2
Y˜
(1− pi). (11)
Regression (2) is equivalent to the following regression:
Yi ∼ τ1Ai + τ0(1−Ai) +
K−1∑
k=1
αk(Ii∈[k] − pn[k]) +
K−1∑
k=1
βkAi(Ii∈[k] − pn[k]).
Let (τˆ1, τˆ0) be the OLS estimator of (τ1, τ0) and let Zinteract be the n× (2K) design matrix with the
ith row(
Ai, 1−Ai, Ii∈[1] − pn[1], . . . , Ii∈[K−1] − pn[K−1], Ai(Ii∈[1] − pn[1]), . . . , Ai(Ii∈[K−1] − pn[K−1])
)
.
By the property of OLS,
τˆinteract = τˆ1 − τˆ0, nσˆ2interact =
(
1
n− 2K
n∑
i=1
rˆ2i,interact
)(
1
n
Z
T
interactZinteract
)
−1
(1,1)+(2,2)−2(1,2)
, (12)
where the subscript (1, 1) + (2, 2) − 2(1, 2) denotes the (1, 1)th element plus the (2, 2)th element
minus 2 times the (1, 2)th element of the matrix. Applying Lemma 2 to each element of the matrix
(1/n)ZTinteractZinteract, we have (1/n)Z
T
interactZinteract
P−→ Σinteract, where
Σinteract =


pi 0 0 · · · 0
0 1− pi 0 · · · 0
0 0
...
... ∗
0 0

 .
Thus,
(Σ−1interact)(1,1)+(2,2)−2(1,2) =
1
pi
+
1
1− pi =
1
pi(1− pi) . (13)
Combing (11), (12) and (13), we have
nσˆ2interact
P−→ ς2
Y˜
(1− pi).
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A.5. Proof of Corollary 1
Proof. When pi = 1/2, ς2piY = 0, thus Proposition 2 and Proposition 3 imply that τˆinteract and τˆadj are
asymptotically equivalent. Since ς2AY (pi) ≥ 0, thus both the asymptotic variances of τˆinteract and τˆadj
are smaller than or equal to that of τˆ . Finally, when pi = 1/2, ς2piY = 0 and
nσˆ2adj
P−→ ς2
Y˜
(1− pi) + ς2HY = ς2Y˜ (pi) + ς2HY ,
therefore, nσˆ2adj is a consistent variance estimator.
A.6. Proof of Theorem 1
Proof. First, we obtain the formula of τˆ ∗. By definition, τˆ ∗ is the OLS estimator of the regression
coefficient of Ai when we regress Yi on Ai and Xi with intercept, which is equivalent to solving the
following equations: 

n−1
∑n
i=1(Yi − α− τAi −XTi γ) = 0
n−1
∑n
i=1Ai(Yi − α− τAi −XTi γ) = 0
n−1
∑n
i=1(Xi − X¯)(Yi − α− τAi −XTi γ)] = 0
Let {αˆ∗, τˆ ∗, (γˆ∗)T}T be the solution of the above equations, then by the first equation, we have
Y¯ − αˆ∗ − A¯τˆ ∗ − X¯Tγˆ∗ = 0.
Thus,
αˆ∗ = Y¯ − τˆ ∗A¯− X¯Tγˆ∗.
Taking it into the second and third equations, we have
Y¯1 − Y¯ − τˆ ∗(1− A¯)− (X¯1 − X¯)Tγˆ∗ = 0, (14)
SXY − τˆ ∗SXA − SXX γˆ∗ = 0.
where
SXY =
1
n
n∑
i=1
(Xi − X¯)(Yi − Y¯ ), SXX = 1
n
n∑
i=1
(Xi − X¯)(Xi − X¯)T,
SXA =
1
n
n∑
i=1
(Xi − X¯)(Ai − A¯) = n1
n
( 1
n1
n∑
i=1
AiXi − X¯
)
=
n1
n
(X¯1 − X¯).
Let γˆ = S−1
XX
SXY , then
γˆ∗ = γˆ − τˆ ∗S−1
XX
SXA. (15)
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Since A¯ = n1/n, taking (15) into (14), we have
τˆ ∗ =
Y¯1 − Y¯ − (X¯1 − X¯)Tγˆ
n0/n− n1/n(X¯1 − X¯)TS−1XX(X¯1 − X¯)
.
Since Y¯ = (n1/n)Y¯1 + (n0/n)Y¯0, we have Y¯1 − Y¯ = (n0/n)(Y¯1 − Y¯0). Similarly
X¯1 − X¯ = (n0/n)(X¯1 − X¯0), X¯0 − X¯ = (n1/n)(X¯0 − X¯1) = −(n1/n0)(X¯1 − X¯).
Therefore, the numerator of τˆ ∗ is
(n0/n)[{Y¯1 − (X¯1 − X¯)Tγˆ} − {Y¯0 − (X¯0 − X¯)Tγˆ}],
and the denominator is
(n0/n){1 + (X¯1 − X¯)TS−1XX(X¯0 − X¯)}
Thus,
τˆ ∗ =
[Y¯1 − (X¯1 − X¯)Tγˆ]− [Y¯0 − (X¯0 − X¯)Tγˆ]
1 + (X¯1 − X¯)TS−1XX(X¯0 − X¯)
.
Second, we prove the asymptotic normality of τˆ ∗, for which we need the following lemma.
Lemma 5. Suppose that (ri(1), ri(0)) ∈ R2 and Assumptions 1, 2 and 4 hold, then
SXX − ΣXX = op(1), γˆ − γ = op(1), X¯1 − X¯ = Op(n−1/2), X¯0 − X¯ = Op(n−1/2).
Lemma 5 can be obtained directly from the strong law of large numbers, Lemmas B.1 and B.2 in
Bugni et al. (2018). We will prove it later. By Lemma 5, the denominator of τˆ ∗ convergences to one
in probability. Thus,
√
n(τˆ ∗ − τ) has the same asymptotic distribution as
√
n
[{Y¯1 − (X¯1 − X¯)Tγˆ} − {Y¯0 − (X¯0 − X¯)Tγˆ} − τ]
=
√
n
[{Y¯1 − (X¯1 − X¯)Tγ} − {Y¯0 − (X¯0 − X¯)Tγ} − τ]
−√n(X¯1 − X¯)T(γˆ − γ) +
√
n(X¯0 − X¯)T(γˆ − γ).
By Lemma 5,
√
n(X¯1 − X¯)T(γˆ − γ) = op(1),
√
n(X¯0 − X¯)T(γˆ − γ) = op(1).
Thus,
√
n(τˆ ∗ − τ) has the same asymptotic distribution as
√
n
[{Y¯1 − (X¯1 − X¯)Tγ} − {Y¯0 − (X¯0 − X¯)Tγ} − τ]
=
√
n{(Y¯1 − X¯1Tγ)− (Y¯0 − X¯0Tγ)− τ}
=
√
n(r¯1 − r¯0 − τ),
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which is
√
n times the difference-in-means estimator minus τ for the transformed outcomes ri(a) =
Yi(a)−XTi γ with E{ri(1)− ri(0)} = τ . By Theorem 1 of Bugni et al. (2018) (Proposition 1 in this
paper), √
n(r¯1 − r¯0 − τ) d−→ N (0, ς2r˜ (pi) + ς2Hr + ς2Ar(pi)).
Finally, we compare the asymptotic variances of τˆ ∗ and τˆ . By Lemma 1,
ς2r˜ (pi) + ς
2
Hr + ς
2
Ar(pi)
= ς2r (pi)−
K∑
k=1
p[k]{pi(1− pi)− q[k]}
{µ[k]r(1)− µr(1)
pi
+
µ[k]r(0)− µr(0)
1− pi
}2
. (16)
By definition, γ(a) = Σ−1
XX
ΣXY (a), a = 0, 1, then
σ2r(a) = σ
2
Y (a)−XTγ = Var[Yi(a)−XTi γ] = σ2Y (a) + γTΣXXγ − 2γTΣXY (a),
= σ2Y (a) + γ
TΣXXγ − 2γTΣXXγ(a).
Thus,
ς2r (pi)− ς2Y (pi) =
{σ2r(1)
pi
+
σ2r(0)
1− pi
}
−
{σ2Y (1)
pi
+
σ2Y (0)
1− pi
}
=
1
pi(1− pi)γ
TΣXXγ − 2
pi(1− pi)γ
TΣXX{(1− pi)γ(1) + piγ(0)}
=
1
pi(1− pi)γ
TΣXXγ − 2
pi(1− pi)γ
TΣXX [γ + (2pi − 1){γ(0)− γ(1)}]
= − 1
pi(1− pi)γ
TΣXXγ +
2(2pi − 1)
pi(1− pi) γ
TΣXX{γ(1)− γ(0)}, (17)
where the third equality is because γ = piγ(1) + (1− pi)γ(0). By definition, for a = 0, 1,
µ[k]r(a)− µr(a) = {µ[k]Y (a)− µY (a)} − (µ[k]X − µX)Tγ.
Thus,
{µ[k]r(1)− µr(1)} − {µ[k]r(0)− µr(0)} = {µ[k]Y (1)− µY (1)} − {µ[k]Y (0)− µY (0)}.
Therefore,
ς2Hr = ς
2
HY , (18)
and
µ[k]r(1)− µr(1)
pi
+
µ[k]r(0)− µr(0)
1− pi
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=
{µ[k]Y (1)− µY (1)}
pi
+
{µ[k]Y (0)− µY (0)}
1− pi −
1
pi(1− pi){µ[k]X − µX}
Tγ,
By Lemma 1,
ς2
Y˜
(pi) + ς2HY + ς
2
AY (pi) = ς
2
Y (pi)−
K∑
k=1
p[k]{pi(1− pi)− q[k]}
{µ[k]Y (1)− µY (1)
pi
+
µ[k]Y (0)− µY (0)
1− pi
}2
.
(19)
Combing (16), (17), (18) and (19), the difference of the asymptotic variances of τˆ ∗ and τˆ is
∆diff∗−diff
= {ς2r˜ (pi) + ς2Hr + ς2Ar(pi)} − {ς2Y˜ (pi) + ς2HY + ς2AY (pi)}
= ς2r (pi)− ς2Y (pi)−
K∑
k=1
p[k]{pi(1− pi)− q[k]}
{µ[k]r(1)− µr(1)
pi
+
µ[k]r(0)− µr(0)
1− pi
}2
+
K∑
k=1
p[k]{pi(1− pi)− q[k]}
{µ[k]Y (1)− µY (1)
pi
+
µ[k]Y (0)− µY (0)
1− pi
}2
= − 1
pi(1− pi)γ
TΣXXγ +
2(2pi − 1)
pi(1− pi) γ
TΣXX{γ(1)− γ(0)}
− 1
pi(1− pi)γ
T
K∑
k=1
p[k]
{
1− q[k]
pi(1− pi)
}
{µ[k]X − µX}{µ[k]X − µX}Tγ
+
2
pi(1− pi)γ
T
K∑
k=1
p[k]
{
1− q[k]
pi(1− pi)
}
{µ[k]X − µX}{(1− pi)(µ[k]Y (1)− µY (1)) + pi(µ[k]Y (0)− µY (0))}.
A.7. Proof of Theorem 2
Proof. First, we derive the formula of τˆ ∗adj. Regression (5):
Yi ∼ τAi +
K∑
k=1
αkIi∈[k] +X
T
i β
is equivalent to first centering the outcome Yi, treatment indicators Ai and covariates Xi at their
stratum-specific means and then running the same regression but without the stratification indicators
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Ii∈[k], that is, the OLS estimator (τˆ
∗
adj, βˆadj) satisfy
(τˆ ∗adj, βˆadj) = argmin
τ,β
K∑
k=1
∑
i∈[k]
{
Yi − Y¯[k] − τ(Ai − pi[k])− (Xi − X¯[k])Tβ
}2
, (20)
where pi[k] = n[k]1/n[k] = A¯[k]. Solve the quadratic optimization problem, we can obtain (given βˆadj,
τˆ ∗adj is the fixed effect estimator (the second regression estimator considered in the main text) applying
to the transformed outcomes Yi(a)−XTi βˆadj
τˆ ∗adj =
K∑
k=1
ω[k]
{
Y¯[k]1 − Y¯[k]0 − (X¯[k]1 − X¯[k]0)Tβˆadj
}
,
βˆadj =
{
Sˆadj
XX
− τˆXadj(τˆXadj)T
K∑
k=1
pi[k](1− pi[k])pn[k]
}
−1{
Sˆadj
XY − τˆadjτˆXadj
K∑
k=1
pi[k](1− pi[k])pn[k]
}
,
where
τˆXadj =
K∑
k=1
ω[k](X¯[k]1 − X¯[k]0),
Sˆadj
XX
=
1
n
K∑
k=1
∑
i∈[k]
(Xi − X¯[k])(Xi − X¯[k])T, SˆadjXY =
1
n
K∑
k=1
∑
i∈[k]
(Xi − X¯[k])(Yi − Y¯[k]).
Second, we prove the asymptotic normality of τˆ ∗adj. We need the following lemma with its proof
given later.
Lemma 6. Suppose that (ri,adj(1), ri,adj(0),Xi) ∈ R2 and Assumptions 1, 2 and 4 hold, then
Sˆadj
XX
P−→ Σ
X˜X˜
, Sˆadj
XY
P−→ piΣ
X˜Y˜ (1) + (1− pi)ΣX˜Y˜ (0), βˆadj − βadj = op(1).
To proceed, let
τˇadj =
K∑
k=1
ω[k]
{
Y¯[k]1 − Y¯[k]0 − (X¯[k]1 − X¯[k]0)Tβadj
}
,
then,
τˆ ∗adj = τˇadj −
K∑
k=1
ω[k](X¯[k]1 − X¯[k]0)T(βˆadj − βadj).
Applying the asymptotic normality of the fixed effect estimator (Proposition 2) to the potential
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outcomes ri,adj(a) = Yi(a)−XTi βadj and the potential outcomes Xi(1) = Xi(0) = Xi, we obtain
√
n(τˇadj − τ) d−→ N (0, ς2r˜adj(pi) + ς2Hradj + ς2piradj),
√
n
K∑
k=1
ω[k](X¯[k]1 − X¯[k]0) d−→ N (0, ς2X˜(pi) + ς2HX + ς2piX).
Note that, when pi = 1/2, the above two asymptotic normality results still hold if we replace As-
sumption 3 by Assumption 4. Together with Lemma 6, we have
√
n(τˆ ∗adj − τ) d−→ N (0, ς2r˜adj(pi) + ς2Hradj + ς2piradj).
Third, we investigate the OLS variance estimator σˆ2∗adj. From (20), τˆ
∗
adj is the fixed effect estimator
(the second regression estimator considered in the main text) applying to the transformed outcomes
Yi(a)−XTi βˆadj, the residual sum of squares is
K∑
k=1
∑
i∈[k]
{Yi − Y¯[k] − τˆ ∗adj(Ai − pi[k])− (Xi − X¯[k])Tβˆadj}2
=
K∑
k=1
∑
i∈[k]
{Yi − Y¯[k] − τˇadj(Ai − pi[k])− (Xi − X¯[k])Tβadj}2
+
K∑
k=1
∑
i∈[k]
{(τˆ ∗adj − τˇadj)(Ai − pi[k]) + (Xi − X¯[k])T(βˆadj − βadj)}2 (21)
−2
K∑
k=1
∑
i∈[k]
{Yi − Y¯[k] − τˇadj(Ai − pi[k])− (Xi − X¯[k])Tβadj}
{(τˆ ∗adj − τˇadj)(Ai − pi[k]) + (Xi − X¯[k])T(βˆadj − βadj)}, (22)
where τˇadj is the fixed effect estimator applying to the transformed outcomes ri,adj(a) = Yi(a)−XTi βadj,
and the corresponding residual sum of squares is
K∑
k=1
∑
i∈[k]
{Yi − Y¯[k] − τˇadj(Ai − pi[k])− (Xi − X¯[k])Tβadj}2.
By Lemma 4 with Yi(a) replaced by ri,adj(a), we have
1
n
K∑
k=1
∑
i∈[k]
{Yi − Y¯[k] − τˇadj(Ai − pi[k])− (Xi − X¯[k])Tβadj}2 P−→ pi(1− pi){ς2r˜adj(pi) + ς2Hradj}. (23)
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For the term in (21), by Lemma 3 and Lemma 6, we have
1
n
K∑
k=1
∑
i∈[k]
(Ai − pi[k])2 =
K∑
k=1
pi[k](1− pi[k])pn[k] P−→ pi(1− pi),
1
n
K∑
k=1
∑
i∈[k]
(Xi − X¯[k])(Xi − X¯[k])T = SˆadjXX P−→ ΣX˜X˜ .
Since τˆ ∗adj and τˇadj have the same asymptotic normality, and βˆadj − βadj = op(1), we have
1
n
K∑
k=1
∑
i∈[k]
{(τˆ ∗adj − τˇadj)(Ai − pi[k]) + (Xi − X¯[k])T(βˆadj − βadj)}2 = op(1). (24)
Combing (23) and (24), and applying Cauchy-Schwarz inequality, the term in (22) converges to zero
in probability. Therefore, the mean residual sum of squares satisfies
1
n
K∑
k=1
∑
i∈[k]
{Yi − Y¯[k] − τˆ ∗adj(Ai − pi[k])− (Xi − X¯[k])Tβˆadj}2 P−→ pi(1− pi){ς2r˜adj(1− pi) + ς2Hradj}. (25)
Moreover, regression (5) is equivalent to the following regression:
Yi ∼ τ1Ai + τ0(1− Ai) +
K−1∑
k=1
αk(Ii∈[k] − pn[k]) + (Xi − X¯)Tβ,
with an n× (K + p+ 1) design matrix Zadj whose ith row is
(Ai, 1−Ai, Ii∈[1] − pn[1], . . . , Ii∈[K−1] − pn[K−1],XTi − X¯T).
By the property of OLS, nσˆ2∗adj is the (1, 1) + (2, 2) − 2(1, 2) element of the inverse of the matrix
(1/n)ZTadjZadj times
1
n−K − p− 1
K∑
k=1
∑
i∈[k]
{Yi − Y¯[k] − τˆ ∗adj(Ai − pi[k])− (Xi − X¯[k])Tβˆadj}2.
Similar to the proof of Proposition 3, the (1, 1) + (2, 2)− 2(1, 2) element of the inverse of the matrix
(1/n)ZTadjZadj converges in probability to {pi(1− pi)}−1, which together with (25) gives
nσˆ2∗adj
P−→ ς2r˜adj(1− pi) + ς2Hradj .
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Note that, the above convergence in probability holds if we replace Assumption 3 by Assumption 4
when pi = 1/2 (only the asymptotic normality of τˆ ∗adj and τˇadj requires Assumption 3, which still holds
under Assumption 4 when pi = 1/2).
Fourth, we prove the consistency of the variance estimator ςˆ2r˜es(pi)+ ςˆ
2
Hres
+ ςˆ2pires. By our definition
of notation,
ςˆ2r˜es(pi) =
1
pi
K∑
k=1
pn[k]
n[k]1
∑
i∈[k]
Ai(ri,es − r¯[k]1,es)2 + 1
1− pi
K∑
k=1
pn[k]
n[k]0
∑
i∈[k]
(1−Ai)(ri,es − r¯[k]0,es)2,
ςˆ2Hres =
K∑
k=1
pn[k]
{
(r¯[k]1,es − r¯1,es)− (r¯[k]0,es − r¯0,es)
}2
,
ςˆ2pires =
(1− 2pi)2
pi2(1− pi)2
K∑
k=1
pn[k]q[k]
[
{r¯[k]1,es − r¯1,es} − {r¯[k]0,es − r¯0,es}
]2
.
Recall that
ri,es(a) = Yi(a)−XTi βˆadj = ri,adj(a)−XTi (βˆadj − βadj),
thus,
ri,es − r¯[k]1,es = ri,adj − r¯[k]1,adj − (Xi − X¯[k]1)T(βˆadj − βadj).
Therefore,
K∑
k=1
pn[k]
n[k]1
∑
i∈[k]
Ai(ri,es − r¯[k]1,es)2
=
K∑
k=1
pn[k]
n[k]1
∑
i∈[k]
Ai{ri,adj − r¯[k]1,adj − (Xi − X¯[k]1)T(βˆadj − βadj)}2
=
K∑
k=1
pn[k]
n[k]1
∑
i∈[k]
Ai(ri,adj − r¯[k]1,adj)2 + (26)
(βˆadj − βadj)T
K∑
k=1
pn[k]
n[k]1
∑
i∈[k]
Ai(Xi − X¯[k]1)(Xi − X¯[k]1)T(βˆadj − βadj)− (27)
2
K∑
k=1
pn[k]
n[k]1
∑
i∈[k]
Ai(ri,adj − r¯[k]1,adj)(Xi − X¯[k]1)T(βˆadj − βadj). (28)
For the first term (26), applying the consistency of the variance estimator part of Proposition 2 to
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ri,adj, we have
K∑
k=1
pn[k]
n[k]1
∑
i∈[k]
Ai(ri,adj − r¯[k]1,adj)2 P−→ σ2r˜adj(1).
For the second term (27), by similar argument in the proof of Lemma 7,
K∑
k=1
pn[k]
n[k]1
∑
i∈[k]
Ai(Xi − X¯[k]1)(Xi − X¯[k]1)T P−→ ΣX˜X˜ .
Since βˆadj − βadj = op(1), thus,
(βˆadj − βadj)T
K∑
k=1
pn[k]
n[k]1
∑
i∈[k]
(Xi − X¯[k]1)(Xi − X¯[k]1)T(βˆadj − βadj) = op(1).
For the third term (28), using Cauchy-Schwarz inequality, we have
K∑
k=1
pn[k]
n[k]1
∑
i∈[k]
Ai(ri,adj − r¯[k]1,adj)(Xi − X¯[k]1)T(βˆadj − βadj) = op(1).
Therefore,
K∑
k=1
pn[k]
n[k]1
∑
i∈[k]
Ai(ri,es − r¯[k]1,es)2 = σ2r˜adj(1) + op(1). (29)
Similarly,
K∑
k=1
pn[k]
n[k]0
∑
i∈[k]
(1−Ai)(ri,es − r¯[k]0,es)2 = σ2r˜adj(0) + op(1). (30)
Combing (29) and (30), we have
ςˆ2r˜es(pi)
P−→ ς2r˜adj(pi).
Using similar arguments, we can prove that
ςˆ2Hres
P−→ ς2Hradj , ςˆ2pires
P−→ ς2piradj.
Therefore, ςˆ2r˜es(pi)+ ςˆ
2
Hres + ςˆ
2
pires is a consistent estimator of the asymptotic variance ς
2
r˜adj
(pi)+ ς2Hradj +
ς2piradj . Note that, the above arguments are valid under Assumptions 1, 2 and 4.
Finally, we compare the asymptotic variances of τˆ ∗adj and τˆadj. Note that ri,adj(a) = Yi(a)−XTi βadj,
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by definition,
µ[k]radj(a)− µradj(a) = µ[k]Y (a)− µY (a)− (µ[k]X − µX)Tβadj.
Thus,
{µ[k]radj(1)− µradj(1)} − {µ[k]radj(0)− µradj(0)} = {µ[k]Y (1)− µY (1)} − {µ[k]Y (0)− µY (0)}.
Therefore,
ς2Hradj = ς
2
HY , ς
2
piradj
= ς2piY . (31)
The difference of asymptotic variances of τˆ ∗adj and τˆadj is
∆adj∗−adj = {ς2r˜adj(pi) + ς2Hradj + ς2piradj} − {ς2Y˜ (pi) + ς2HY + ς2piY } = ς2r˜adj(pi)− ς2Y˜ (pi). (32)
By definition and simple calculation,
σ2r˜adj(a) = Var[Yi(a)−E{Yi(a)|Bi} − (Xi − E{Xi|Bi})Tβadj]
= Var[Y˜ (a)] + βTadjΣX˜X˜βadj − 2βTadjΣX˜Y˜ (a)
Thus,
ς2r˜adj(pi) =
σ2r˜adj(1)
pi
+
σ2r˜adj(0)
1− pi
= ς2
Y˜
(pi) +
( 1
pi
+
1
1− pi
)
βTadjΣX˜X˜βadj −
2
pi
βTadjΣX˜Y˜ (1) −
2
1− piβ
T
adjΣX˜Y˜ (0)
= ς2
Y˜
(pi) +
1
pi(1− pi)
(
βTadjΣX˜X˜βadj − 2(1− pi)βTadjΣX˜Y˜ (1) − 2piβTadjΣX˜Y˜ (0)
)
.
By definition, βadj = piβ(1) + (1− pi)β(0), where
β(1) = Σ−1
X˜X˜
Σ
X˜Y˜ (1), β(0) = Σ
−1
X˜X˜
Σ
X˜Y˜ (0).
By simple calculation (similar to the argument for ς2r˜adj(pi), just replacing γ, γ(1) and γ(0) by βadj,
β(1) and β(0), respectively),
ς2r˜adj(pi) = ς
2
Y˜
(pi)− 1
pi(1− pi)β
T
adjΣX˜X˜βadj +
2(2pi − 1)
pi(1− pi) β
T
adjΣX˜X˜{β(1)− β(0)}. (33)
Combing (32) and (33), the difference of asymptotic variances of τˆ ∗adj and τˆadj is
∆adj∗−adj = − 1
pi(1− pi)β
T
adjΣX˜X˜βadj +
2(2pi − 1)
pi(1− pi) β
T
adjΣX˜X˜{β(1)− β(0)}.
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A.8. Proof of Theorem 3
First, we obtain the formula of τˆ ∗interact. The coefficient of Ai in regression (6) is the OLS estimator
of τ1 − τ0 in the following regression:
Yi ∼ Aiτ1 + (1− Ai)τ0 +
K∑
k=1
αk1Ai[Ii∈[k] − pn[k]] +
K∑
k=1
αk0(1−Ai)[Ii∈[k] − pn[k]]
+Ai
(
Xi −
K∑
k=1
Ii∈[k]X¯[k]
)T
β(1) + (1−Ai)
(
Xi −
K∑
k=1
Ii∈[k]X¯[k]
)T
β(0). (34)
Note that the over-parameterization does not affect the OLS estimator of τ1−τ0. The above regression
is equivalent to running two regressions, in the treatment and control groups, separately:
Yi(1) ∼ τ1 −
K∑
k=1
αk1pn[k] +
K∑
k=1
αk1Ii∈[k] +
(
Xi −
K∑
k=1
Ii∈[k]X¯[k]
)T
β(1), Ai = 1 (35)
Yi(0) ∼ τ0 −
K∑
k=1
αk0pn[k] +
K∑
k=1
αk0Ii∈[k] +
(
Xi −
K∑
k=1
Ii∈[k]X¯[k]
)T
β(0), Ai = 0.
The OLS estimator of regression (35) satisfies,
τˆ1 −
K∑
k=1
αˆk1pn[k] − αˆk1 = Y¯[k]1 − (X¯[k]1 − X¯[k])Tβˆ(1), k = 1, . . . , K, (36)
βˆ(1) = S−1
X˜X˜
(1)S
X˜Y˜ (1),
where
S
X˜X˜
(1) =
1
n1
K∑
k=1
∑
i∈[k]
Ai(Xi − X¯[k]1)(Xi − X¯[k]1)T,
S
X˜Y˜ (1) =
1
n1
K∑
k=1
∑
i∈[k]
Ai(Xi − X¯[k]1){Yi(1)− Y¯[k]1}.
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Taking average weighted by pn[k] of both hands sides of (36), we have (note that
∑K
k=1 pn[k] = 1)
τˆ1 =
K∑
k=1
pn[k]
{
Y¯[k]1 − (X¯[k]1 − X¯[k])Tβˆ(1)
}
.
Similarly,
τˆ0 =
K∑
k=1
pn[k]
{
Y¯[k]0 − (X¯[k]0 − X¯[k])Tβˆ(0)
}
,
where
βˆ(0) = S−1
X˜X˜
(0)S
X˜Y˜ (0),
S
X˜X˜
(0) =
1
n0
K∑
k=1
∑
i∈[k]
(1− Ai)(Xi − X¯[k]0)(Xi − X¯[k]0)T,
S
X˜Y˜ (0) =
1
n0
K∑
k=1
∑
i∈[k]
(1−Ai)(Xi − X¯[k]0){Yi(0)− Y¯[k]0).
Thus,
τˆ ∗interact = τˆ1 − τˆ0 =
K∑
k=1
pn[k]
[{
Y¯[k]1 − (X¯[k]1 − X¯[k])Tβˆ(1)
}
−
{
Y¯[k]0 − (X¯[k]0 − X¯[k])Tβˆ(0)
}]
. (37)
Second, we prove the asymptotic normality of τˆ ∗interact. We introduce the following lemma with
proof given later.
Lemma 7. Suppose that (ri,interact(1), ri,interact(0)) ∈ R2 and Assumptions 1, 2 and 4 hold, then
S
X˜X˜
(a)
P−→ Σ
X˜X˜
, S
X˜Y˜ (a)
P−→ Σ
X˜Y˜ (a), βˆ(a)
P−→ β(a), a = 0, 1.
It is easy to see that
X¯[k] = pi[k]X¯[k]1 + (1− pi[k])X¯[k]0.
Thus,
X¯[k]1 − X¯[k] = (1− pi[k])(X¯[k]1 − X¯[k]0), X¯[k]0 − X¯[k] = −pi[k](X¯[k]1 − X¯[k]0).
Taking them into (37), we have
τˆ ∗interact
=
K∑
k=1
pn[k]
[{
Y¯[k]1 − (X¯[k]1 − X¯[k])Tβˆ(1)
}
−
{
Y¯[k]0 − (X¯[k]0 − X¯[k])Tβˆ(0)
}]
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=
K∑
k=1
pn[k]
[
Y¯[k]1 − Y¯[k]0 − (X¯[k]1 − X¯[k]0)T
{
(1− pi[k])βˆ(1) + pi[k]βˆ(0)
}]
=
K∑
k=1
pn[k]
[
Y¯[k]1 − Y¯[k]0 − (X¯[k]1 − X¯[k]0)Tβinteract
]
−
K∑
k=1
pn[k](X¯[k]1 − X¯[k]0)T{βˆinteract − βinteract},
where βˆinteract = (1 − pi[k])βˆ(1) + pi[k]βˆ(0). By Lemma 3, pn[k] P−→ p[k], and applying the asymptotic
normality of stratified difference-in-means estimator (Proposition 3) to the transformed outcomes
Ri(a) = XiIi∈[k], a = 0, 1, we have X¯[k]1 − X¯[k]0 = Op(n−1/2), thus,
K∑
k=1
pn[k](X¯[k]1 − X¯[k]0) = Op(n−1/2).
By Lemma 7 and pi[k] = n[k]1/n[k]
P−→ pi, we have
βˆinteract − βinteract = op(1).
Thus,
√
n
K∑
k=1
pn[k](X¯[k]1 − X¯[k]0)T{βˆinteract − βinteract} = op(1).
Therefore, τˆ ∗interact has the same asymptotic distribution as
K∑
k=1
pn[k]
[
Y¯[k]1 − Y¯[k]0 − (X¯[k]1 − X¯[k]0)Tβinteract
]
,
which is the stratified difference-in-means estimator (the third regression estimator in the main text)
applied to the transformed outcomes ri,interact(a) = Yi(a)−XTi βinteract. By the asymptotic normality
result of Proposition 3,
√
n(τˆ ∗interact − τ) d−→ N (0, ς2r˜interact(pi) + ς2Hrinteract).
Third, we study the asymptotic property of the OLS variance estimator σˆ2∗interact. By the proper-
ties of OLS, nσˆ2∗interact equals the (1, 1) + (2, 2) − 2(1, 2) element of the inverse of the Gram matrix
(1/n)ZTinteractZinteract in regression (34) times
∑n
i=1 rˆ
2
i,interact/(n − 2K − 2p), where rˆi,interact is the
residual of the regression which satisfies
1
n
n∑
i=1
rˆ2i,interact
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=
1
n
K∑
k=1
∑
i∈[k]
Ai
{
Yi − Y¯[k]1 − (Xi − X¯[k]1)Tβˆ(1)
}2
+ (1− Ai)
{
Yi − Y¯[k]0 − (Xi − X¯[k]0)Tβˆ(0)
}2
.
For the first term, note that
Yi − Y¯[k]1 − (Xi − X¯[k]1)Tβˆ(1) = Yi − Y¯[k]1 − (Xi − X¯[k]1)Tβ(1) + (Xi − X¯[k]1)T{β(1)− βˆ(1)},
thus,
1
n
K∑
k=1
∑
i∈[k]
Ai
{
Yi − Y¯[k]1 − (Xi − X¯[k]1)Tβˆ(1)
}2
=
1
n
K∑
k=1
∑
i∈[k]
Ai
{
Yi − Y¯[k]1 − (Xi − X¯[k]1)Tβ(1)
}2
+
n1
n
{β(1)− βˆ(1)}TS
X˜X˜
(1){β(1)− βˆ(1)}+
2
n
K∑
k=1
∑
i∈[k]
Ai{Yi − Y¯[k]1 − (Xi − X¯[k]1)Tβ(1)}(Xi − X¯[k]1)T{β(1)− βˆ(1)} (38)
By Lemma 7,
n1
n
{β(1)− βˆ(1)}TS
X˜X˜
(1){β(1)− βˆ(1)} = op(1).
Let ui(a) = Yi(a)−XTi β(a), a = 0, 1, then
1
n
K∑
k=1
∑
i∈[k]
Ai
{
Yi − Y¯[k]1 − (Xi − X¯[k]1)Tβ(1)
}2
=
1
n
K∑
k=1
∑
i∈[k]
Ai
{
ui(1)− u¯[k]1
}2
=
1
n
n∑
i=1
Aiu
2
i (1)−
K∑
k=1
n[k]1
n
(u¯[k]1)
2
P−→ piE{u2i (1)} − piE[E{ui(1)|Bi}]2
= piσ2u˜(1),
where the convergence in probability is due to Lemma 2 and Lemma 3. Using Cauchy-Schwarz
inequality for the third term of (38), we have it converges to zero in probability. Thus,
1
n
K∑
k=1
∑
i∈[k]
Ai
{
Yi − Y¯[k]1 − (Xi − X¯[k]1)Tβˆ(1)
}2 P−→ piσ2u˜(1).
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Similarly,
1
n
K∑
k=1
∑
i∈[k]
(1− Ai)
{
Yi − Y¯[k]0 − (Xi − X¯[k]0)Tβˆ(0)
}2 P−→ (1− pi)σ2u˜(0).
Thus,
1
n
n∑
i=1
rˆ2i,interact
P−→ piσ2u˜(1) + (1− pi)σ2u˜(0).
Similar to the third part of the proof of Theorem 2, the (1, 1)+ (2, 2)− 2(1, 2) element of the inverse
of the matrix (1/n)ZTinteractZinteract converges in probability to {pi(1− pi)}−1. Therefore,
nσˆ2∗interact
P−→ σ
2
u˜(1)
1− pi +
σ2u˜(0)
pi
.
Since
ui(1) = Yi(1)−XTi β(1) = ri,interact(1)−XTi {β(1)− βinteract},
then
σ2u˜(1) = σ
2
r˜interact(1)
+ {β(1)− βinteract}TΣX˜X˜{β(1)− βinteract} − 2{β(1)− βinteract}TΣX˜ r˜interact(1)
= σ2r˜interact(1) − {β(1)− βinteract}TΣX˜X˜{β(1)− βinteract},
where the last equality holds because
Σ
X˜ r˜interact(1)
= Σ
X˜Y˜ (1) − ΣX˜X˜βinteract = ΣX˜X˜{β(1)− βinteract}.
Therefore,
σ2u˜(1)
1− pi +
σ2u˜(0)
pi
= ς2r˜interact(1− pi)−
1
1− pi{β(1)− βinteract}
TΣ
X˜X˜
{β(1)− βinteract} −
1
pi
{β(0)− βinteract}TΣX˜X˜{β(0)− βinteract}
= ς2r˜interact(1− pi)−
{ 1
pi(1− pi) − 3
}
{β(1)− β(0)}TΣ
X˜X˜
{β(1)− β(0)}.
Fourth, we prove the consistency of the variance estimator ςˆ2r˜es2(pi) + ςˆ
2
Hres2
. Note that
ri,es2(a) = Yi(a)−XTi βˆinteract = ri,interact(a)−XTi (βˆinteract − βinteract).
We have shown that βˆinteract − βinteract = op(1), thus, using similar arguments as in the fourth part of
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the proof of Theorem 2, we can obtain the consistency of the variance estimator, that is,
ςˆ2r˜es2(pi) + ςˆ
2
Hres2
P−→ ςˆ2r˜interact(pi) + ςˆ2Hrinteract .
Fifth, we compare the asymptotic variances of τˆ ∗interact and τˆinteract. Simple calculation gives
σ2r˜interact(a) = Var[Yi(a)−E{Yi(a)|Bi} − (Xi − E{Xi|Bi}Tβinteract]
= σ2
Y˜ (a)
+ βTinteractΣX˜X˜βinteract − 2βTinteractΣX˜Y˜ (a)
= σ2
Y˜ (a)
+ βTinteractΣX˜X˜βinteract − 2βTinteractΣX˜X˜β(a),
where the last equality is because β(a) = Σ−1
X˜X˜
Σ
X˜Y˜ (a). Therefore,
ς2r˜interact(pi)− ς2Y˜ (pi)
=
σ2r˜interact(1) − σ2Y˜ (1)
pi
+
σ2r˜interact(0) − σ2Y˜ (0)
1− pi
=
1
pi
βTinteractΣX˜X˜βinteract +
1
1− piβ
T
interactΣX˜X˜βinteract −
2
pi
βTinteractΣX˜X˜β(1)−
2
1− piβ
T
interactΣX˜X˜β(0)
=
1
pi(1− pi)β
T
interactΣX˜X˜βinteract −
2
pi(1− pi)β
T
interactΣX˜X˜{(1− pi)β(1) + piβ(0)}
= − 1
pi(1− pi)β
T
interactΣX˜X˜βinteract, (39)
where the last equality is because βinteract = (1− pi)β(1) + piβ(0). Since
µ[k]rinteract(a)− µrinteract(a) = µ[k]Y (a)− µY (a)− (µ[k]X − µX)Tβinteract,
then,
{µ[k]rinteract(1)− µrinteract(1)}− {µ[k]rinteract(0)− µrinteract(0)} = {µ[k]Y (1)− µY (1)} − {µ[k]Y (0)− µY (0)}.
Therefore,
ς2Hrinteract = ς
2
HY . (40)
Combing (39) and (40), the difference of the asymptotic variances of τˆ ∗interact and τˆinteract is
∆interact∗−interact = {ς2r˜interact(pi) + ς2Hrinteract} − {ς2Y˜ (pi) + ς2HY }
= ς2r˜interact(pi)− ς2Y˜ (pi)
= − 1
pi(1− pi)β
T
interactΣX˜X˜βinteract ≤ 0.
45
Finally, we compare the asymptotic variances of τˆ ∗interact and τˆ
∗
adj. We have showed in (33) that
ς2r˜adj(pi) = ς
2
Y˜
(pi)− 1
pi(1− pi)β
T
adjΣX˜X˜βadj +
2(2pi − 1)
pi(1− pi) β
T
adjΣX˜X˜{β(1)− β(0)}. (41)
Combing (39) – (41) and (31), the difference of asymptotic variances of τˆ ∗interact and τˆ
∗
adj is
∆interact∗−adj∗
= {ς2r˜interact(pi) + ς2Hrinteract} − {ς2r˜adj(pi) + ς2Hradj + ς2piradj}
= − 1
pi(1− pi)β
T
interactΣX˜X˜βinteract +
1
pi(1− pi)β
T
adjΣX˜X˜βadj −
2(2pi − 1)
pi(1− pi) β
T
adjΣX˜X˜{β(1)− β(0)} − ς2piradj
= − 1
pi(1− pi)
[
βTinteractΣX˜X˜βinteract − βTadjΣX˜X˜βadj + 2βTadjΣX˜X˜(2pi − 1){β(1)− β(0)}
]
− ς2piradj
= − 1
pi(1− pi)
[
βTinteractΣX˜X˜βinteract − βTadjΣX˜X˜βadj + 2βTadjΣX˜X˜{βadj − βinteract}
]
− ς2piradj
= − 1
pi(1− pi)(βinteract − βadj)
TΣ
X˜X˜
(βinteract − βadj)T − ς2piradj .
A.9. Proof of Corollary 2
Proof. By Theorem 3, the difference of the asymptotic variances of τˆ ∗interact and τˆ
∗
adj is
∆interact∗−adj∗ = − 1
pi(1 − pi)(βinteract − βadj)
TΣ
X˜X˜
(βinteract − βadj)T − ς2piradj .
When pi = 1/2, it holds that
βinteract = (1− pi)β(1) + piβ(0) = piβ(1) + (1− pi)β(0) = βadj, ς2piradj = 0.
Therefore, ∆interact∗−adj∗ = 0, i.e., τˆ
∗
interact and τˆ
∗
adj are asymptotically equivalent. By Theorem 3, both
of them are generally more efficient than τˆinteract. For the consistency of the variance estimator, by
Theorem 2,
nσˆ2∗adj
P−→ ς2r˜adj(1− pi) + ς2Hradj ,
and the asymptotic variance of τˆ ∗adj is ς
2
r˜adj
(pi) + ς2Hradj + ς
2
piradj
. When pi = 1/2, it holds that
ς2r˜adj(1− pi) = ς2r˜adj(pi), ς2piradj = 0, ςˆ2pires = 0.
Thus, both nσˆ2∗adj and ςˆ
2
r˜es2
(pi) + ςˆ2Hres2 are consistent variance estimators.
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A.10. Proof of Theorem 4
Proof. Since
X¯1 − X¯ = X¯1 − n1
n
X¯1 − n0
n
X¯0 =
n0
n
(X¯1 − X¯0), X¯0 − X¯ = −n1
n
(X¯1 − X¯0),
then, by definition and simple calculation, we have
τˆ ∗(ηˆ(1), ηˆ(0)) = {Y¯1 − (X¯1 − X¯)Tηˆ(1)} − {Y¯0 − (X¯0 − X¯)Tηˆ(0)}
= Y¯1 − Y¯0 − (X¯1 − X¯0)T
{n0
n
ηˆ(1) +
n0
n
ηˆ(0)
}
= Y¯1 − Y¯0 − (X¯1 − X¯0)Tη − (X¯1 − X¯0)T
{n0
n
ηˆ(1) +
n0
n
ηˆ(0)− η
}
,
where η = (1− pi)η(1) + piη(0). Since
X¯1 − X¯0 = Op(n−1/2), n0
n
ηˆ(1) +
n0
n
ηˆ(0)
P−→ η,
then τˆ ∗(ηˆ(1), ηˆ(0)) has the same asymptotic distribution as
Y¯1 − Y¯0 − (X¯1 − X¯0)Tη,
which is the difference-in-means estimator for the transformed outcomes ri,gen(a) = Yi(a) −XTi η,
a = 0, 1. Applying Proposition 1, we have
√
n
(
τˆ ∗(ηˆ(1), ηˆ(0))− τ) d−→ N (0, ς2r˜gen(pi) + ς2Hrgen + ς2Argen(pi)).
Similarly, we can show that
√
n
(
τˆ ∗adj(ηˆ(1), ηˆ(0))− τ
) d−→ N (0, ς2r˜gen(pi) + ς2Hrgen + ς2pirgen(pi)),
√
n
(
τˆ ∗interact(ηˆ(1), ηˆ(0))− τ
) d−→ N (0, ς2r˜gen(pi) + ς2Hrgen).
Similar to the proof of Theorem 3,
ς2Hrgen = ς
2
HY .
Since ς2Argen , ς
2
pirgen ≥ 0, thus if ηopt minimizes ς2r˜gen(pi), the corresponding estimator τˆ ∗interact(ηˆ(1), ηˆ(0))
has the smallest asymptotic variance. By definition and simple calculus,
ς2r˜gen(pi) =
σ2r˜gen(1)
pi
+
σ2r˜gen(0)
1− pi
=
Var{Y˜i(1)− X˜Ti η}
pi
+
Var{Y˜i(0)− X˜Ti η}
1− pi
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=
Var{Y˜i(1)}
pi
+
Var{Y˜i(0)}
1− pi +
1
pi(1− pi)η
TΣ
X˜X˜
η − 2
pi(1− pi)η
T
{
(1− pi)Σ
X˜Y˜ (1) + piΣX˜Y˜ (0)
}
=
Var{Y˜i(1)}
pi
+
Var{Y˜i(0)}
1− pi +
1
pi(1− pi)η
TΣ
X˜X˜
η − 2
pi(1− pi)η
TΣ
X˜X˜
{
(1− pi)β(1) + piβ˜(0)
}
=
Var{Y˜i(1)}
pi
+
Var{Y˜i(0)}
1− pi +
1
pi(1− pi)η
TΣ
X˜X˜
η − 2
pi(1− pi)η
TΣ
X˜X˜
βinteract,
where the last but second equality is because β(a) = Σ−1
X˜X˜
Σ
X˜Y˜ (a), a = 0, 1, and the last equality is
because βinteract = (1 − pi)β(1) + piβ(0). Taking derivative with respect to η, the optimal coefficient
vector ηopt should satisfy
2Σ
X˜X˜
ηopt − 2ΣX˜X˜βinteract = 0.
That is, ηopt = βinteract. Since τˆ
∗
interact = τˆ
∗
interact(βˆ(1), βˆ(0)) and
βˆ(1)
P−→ β(1), βˆ(0) P−→ β(0), βˆinteract P−→ βinteract,
then, τˆ ∗interact achieves the smallest asymptotic variance. The conclusion follows immediately.
A.11. Proof of Lemma 5
By the strong low of large numbers, for j, k = 1, . . . , p,
X¯
P−→ E(X), 1
n
K∑
k=1
∑
i∈[k]
xijxik
P−→ E(xijxik),
thus,
SXX =
1
n
n∑
i=1
(Xi−X¯)(Xi−X¯)T = 1
n
K∑
k=1
∑
i∈[k]
XiX
T
i −X¯X¯T P−→ E(XXT)−E(X)E(XT) = ΣXX .
Since Yi = AiYi(1) + (1− Ai)Yi(0), by Lemma 2,
Y¯ =
1
n
n∑
i=1
AiYi(1) +
1
n
n∑
i=1
(1−Ai)Yi(0) P−→ piE{Y (1)}+ (1− pi)E{Y (0)}.
Similarly,
1
n
n∑
i=1
XiYi =
1
n
n∑
i=1
AiXiYi(1) +
1
n
n∑
i=1
(1−Ai)XiYi(0) P−→ piE{XY (1)}+ (1− pi)E{XY (0)}.
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Thus,
SXY =
1
n
n∑
i=1
(Xi − X¯)(Yi − Y¯ ) = 1
n
n∑
i=1
XiYi − X¯Y¯
P−→ piE{X − E(X)}[Y (1)−E{Y (1)}] + (1− pi)E{X −E(X)}[Y (0)− E{Y (0)}].
Therefore,
γˆ = S−1
XX
SXY
P−→ ΣXX(piΣXY (1) + (1− pi)ΣXY (0)) = piγ(1) + (1− pi)γ(0) = γ.
In the proof of Theorem 1, we have shown that
X¯1 − X¯ = (n0/n)(X¯1 − X¯0).
Since the covariates X are not affected by the treatment assignment, the treatment effect for X is
τX = 0, then applying the asymptotic theory (Proposition 1 or Theorem 4.1 of Bugni et al. (2018))
to the difference-in-means estimator X¯1 − X¯0, we have X¯1 − X¯0 = Op(n−1/2) under Assumptions 1
– 3. Note that, since Xi(1) = Xi(0) = Xi, the third term of the asymptotic variance of X¯1 − X¯0
(requiring Assumption 3) vanishes even when pi 6= 1/2. The conclusion that X¯1 − X¯0 = Op(n−1/2)
still holds if Assumption 3 is replaced by the weaker Assumption 4.
By Lemma 3, n0/n
P−→ 1− pi, therefore,
X¯1 − X¯ = Op(n−1/2).
Similarly,
X¯0 − X¯ = Op(n−1/2).
A.12. Proof of Lemma 6
Proof. Since the covariates X are not affected by the treatment assignment, the treatment effect for
X is τX = 0, then applying the asymptotic theory (Proposition 2) to the fixed effect estimator τˆXadj,
we have τˆXadj = Op(n
−1/2). Again, note that, to obtain the Op result, we only require Assumption 4
instead of Assumption 3 since the third term of the asymptotic variance of τˆXadj vanishes. Applying
the strong low of large number,
1
n
K∑
k=1
∑
i∈[k]
xijxik
P−→ E(xijxik), 1
n
n∑
i=1
XiIi∈[k]
P−→ E(XiIi∈[k]),
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thus,
1
n
K∑
k=1
∑
i∈[k]
XiX
T
i
P−→ E(XXT),
and
X¯[k] =
1
n[k]
∑
i∈[k]
Xi =
n
n[k]
1
n
n∑
i=1
XiIi∈[k]
P−→ E(XiIi∈[k])
p[k]
= µ[k]X.
Therefore
Sˆadj
XX
=
1
n
K∑
k=1
∑
i∈[k]
(Xi − X¯[k])(Xi − X¯[k])T
=
1
n
K∑
k=1
∑
i∈[k]
XiX
T
i −
K∑
k=1
n[k]
n
X¯[k]X¯
T
[k]
P−→ E(XX)−
K∑
k=1
p[k]µ[k]Xµ
T
[k]X
= E{X −E(X|B)}{X − E(X|B)}T = Σ
X˜X˜
.
For Sˆadj
XY , by Lemma 2,
1
n
n∑
i=1
XiYi =
1
n
n∑
i=1
AiXiYi(1) +
1
n
n∑
i=1
(1−Ai)XiYi(0) P−→ piE{XY (1)}+ (1− pi)E{XY (0)},
Y¯[k] =
1
n[k]
∑
i∈[k]
Yi =
n
n[k]
1
n
n∑
i=1
AiYi(1)Ii∈[k] +
n
n[k]
1
n
n∑
i=1
(1−Ai)Yi(0)Ii∈[k]
P−→ piE{Y (1)|B = k}+ (1− pi)E{Y (0)|B = k}.
Therefore,
Sˆadj
XY =
1
n
n∑
i=1
XiYi −
K∑
k=1
n[k]
n
X¯[k]Y¯[k]
P−→ piE{XY (1)}+ (1− pi)E{XY (0)} − piE(X|B)E{Yi(1)|B} − (1− pi)E(X|B)E{Yi(0)|B}
= piE{X − E(X|B)}[Y (1)−E{Y (1)|B}] + (1− pi)E{X −E(X|B)}[Y (0)− E{Y (0)|B}]
= piΣ
X˜Y˜ (1) + (1− pi)ΣX˜Y˜ (0).
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Finally, from the formula of τˆadj and applying Lemma 2, we can obtain τˆadj = Op(1). Together with
τˆXadj = Op(n
−1/2) and
K∑
k=1
pi[k](1− pi[k])pn[k] P−→
K∑
k=1
pi(1− pi)p[k] = pi(1− pi),
we have
βˆadj − βadj = op(1),
where
βadj = piβ(1) + (1− pi)β(0) = piΣ−1
X˜X˜
Σ
X˜Y˜ (1) + (1− pi)Σ−1X˜X˜ΣX˜Y˜ (0).
A.13. Proof of Lemma 7
Proof. It is enough to show that
S
X˜X˜
(a)
P−→ Σ
X˜X˜
, S
X˜Y (a)
P−→ Σ
X˜Y (a), a = 0, 1.
By definition
S
X˜X˜
(1) =
1
n1
K∑
k=1
∑
i∈[k]
Ai(Xi − X¯[k]1)(Xi − X¯[k]1)T
=
1
n1
K∑
k=1
∑
i∈[k]
AiXiX
T
i −
1
n1
K∑
k=1
n[k]1(X¯[k]1)(X¯[k]1)
T.
Applying Lemma 2 to each element of the matrix XiX
T
i , we have
1
n1
K∑
k=1
∑
i∈[k]
AiXiX
T
i =
n
n1
1
n
K∑
k=1
∑
i∈[k]
AiXiX
T
i
P−→ E(XXT).
Moreover,
X¯[k]1 =
1
n[k]1
n∑
i=1
AiIi∈[k]Xi =
n
n[k]1
1
n
n∑
i=1
AiIi∈[k]Xi
P−→ 1
pip[k]
piE(XiIi∈[k]) = E(Xi|Bi = k).
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Since n[k]1/n1
P−→ p[k], thus,
1
n1
K∑
k=1
n[k]1(X¯[k]1)(X¯[k]1)
T P−→
K∑
k=1
p[k]E(Xi|Bi = k)E(XTi |Bi = k) = E{E(X|B)E(XT|B)}.
Recall that X˜ = X − E(X|B), therefore,
S
X˜X˜
(1)
P−→ E(XXT)−E{E(X|B)E(XT|B)} = E(X˜X˜T) = Σ
X˜X˜
.
Similarly, we can prove that
S
X˜X˜
(0)
P−→ Σ
X˜X˜
, S
X˜Y˜ (1)
P−→ Σ
X˜Y˜ (1), SX˜Y˜ (0)
P−→ Σ
X˜Y˜ (0).
B. Additional Simulation Results
Table 6 and Table 7 present the simulation results obtained under stratified randomization with
Efron’s biased-coin design (Efron, 1971) and Wei’s urn design (Wei, 1978), and the covariate-adaptive
randomization proposed by Hu and Hu (2012). The data-generating models are the same as those
described in section 6 of the main text. First, the six treatment-effect estimators still have small
finite-sample biases, but τˆ and τˆ ∗ appear to have larger biases with unequal allocation. Second, the
standard deviations of τˆ , τˆadj, and τˆinteract are almost identical under a stratified biased-coin design and
the randomization method proposed by Hu and Hu (2012), both of which achieve strong balance. For
randomization methods that satisfy Assumption 3, we can see that the larger is q[k], the larger are the
standard deviations of τˆ . More precisely, the standard deviations of τˆ under complete randomization
and the stratified Wei’s urn design are 2.27%− 69.41% and 0.57%− 30.59%, respectively, which are
larger than those obtained using the stratified biased-coin design and stratified block randomization.
Other relationships between the six estimators are consistent with those reported in the main text.
Third, the OLS and Huber–White variance estimators are only valid for τˆadj and τˆ
∗
adj under equal
allocation, whereas the proposed variance estimators are always valid and exhibit the expected 95%
coverage probability under all scenarios.
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Table 6: Simulated biases, standard deviations, standard errors, and coverage probabilities for dif-
ferent estimators and randomization methods under equal allocation (pi = 1/2)
Stratified Biased-Coin Design Stratified Wei’s Urn Design Hu and Hu’s Randomization
Bias SD SE CP Bias SD SE CP Bias SD SE CP
Model Estimator NEW OLS HW NEW OLS HW NEW OLS HW NEW OLS HW NEW OLS HW NEW OLS HW
1 τˆ 0.00 0.85 0.83 1.01 1.01 0.94 0.98 0.98 -0.01 0.89 0.90 1.02 1.02 0.95 0.98 0.98 -0.07 0.85 0.83 1.02 1.01 0.95 0.98 0.98
τˆadj 0.00 0.85 0.83 0.83 0.83 0.94 0.95 0.94 -0.00 0.82 0.83 0.84 0.83 0.96 0.96 0.96 -0.07 0.85 0.83 0.84 0.83 0.95 0.96 0.95
τˆinteract 0.00 0.85 0.83 0.83 0.82 0.94 0.94 0.94 -0.00 0.82 0.83 0.84 0.83 0.96 0.96 0.96 -0.07 0.85 0.83 0.84 0.83 0.95 0.95 0.95
τˆ ∗ 0.01 0.42 0.40 0.71 0.70 0.94 1.00 1.00 -0.02 0.52 0.52 0.71 0.70 0.95 0.99 0.99 -0.01 0.41 0.40 0.71 0.70 0.95 1.00 1.00
τˆ ∗adj 0.01 0.41 0.40 0.41 0.40 0.94 0.95 0.94 -0.00 0.40 0.40 0.41 0.40 0.95 0.95 0.95 -0.02 0.41 0.40 0.41 0.40 0.94 0.95 0.95
τˆ ∗interact 0.01 0.41 0.40 0.41 0.40 0.94 0.95 0.94 -0.00 0.40 0.40 0.41 0.40 0.95 0.95 0.95 -0.02 0.41 0.40 0.41 0.40 0.94 0.95 0.94
2 τˆ -0.01 0.84 0.84 1.12 1.12 0.95 0.99 0.99 -0.02 0.94 0.94 1.12 1.12 0.95 0.98 0.98 -0.02 0.87 0.84 1.12 1.12 0.94 0.99 0.99
τˆadj -0.02 0.84 0.84 0.84 0.84 0.95 0.95 0.95 -0.04 0.83 0.84 0.84 0.84 0.95 0.95 0.95 -0.03 0.85 0.84 0.84 0.84 0.94 0.94 0.94
τˆinteract -0.01 0.84 0.84 0.41 0.41 0.95 0.67 0.66 -0.02 0.84 0.84 0.41 0.41 0.95 0.67 0.67 -0.02 0.85 0.84 0.41 0.41 0.94 0.66 0.66
τˆ ∗ 0.00 0.82 0.82 1.09 1.09 0.96 0.99 0.99 -0.01 0.92 0.92 1.09 1.09 0.94 0.98 0.98 -0.01 0.86 0.82 1.09 1.09 0.94 0.99 0.99
τˆ ∗adj 0.01 0.82 0.82 0.83 0.82 0.95 0.95 0.95 -0.02 0.82 0.82 0.83 0.83 0.95 0.96 0.96 -0.01 0.84 0.82 0.83 0.82 0.94 0.95 0.95
τˆ ∗interact -0.00 0.82 0.82 0.35 0.35 0.95 0.60 0.60 -0.02 0.82 0.82 0.35 0.35 0.95 0.61 0.61 -0.01 0.84 0.82 0.35 0.35 0.95 0.59 0.59
3 τˆ -0.04 1.92 1.94 2.00 2.00 0.96 0.96 0.96 -0.04 1.94 1.96 2.00 2.00 0.95 0.95 0.96 -0.01 1.90 1.94 2.00 2.00 0.95 0.95 0.95
τˆadj -0.04 1.92 1.94 1.94 1.94 0.96 0.96 0.96 -0.02 1.92 1.94 1.94 1.94 0.95 0.95 0.95 -0.01 1.89 1.94 1.94 1.94 0.95 0.95 0.95
τˆinteract -0.04 1.92 1.94 1.77 1.76 0.96 0.94 0.94 -0.03 1.92 1.94 1.76 1.76 0.95 0.92 0.92 -0.01 1.89 1.94 1.76 1.76 0.95 0.92 0.92
τˆ ∗ -0.09 1.49 1.49 1.54 1.54 0.95 0.96 0.95 -0.04 1.48 1.50 1.54 1.54 0.95 0.96 0.95 -0.03 1.47 1.48 1.54 1.54 0.95 0.96 0.95
τˆ ∗adj -0.09 1.49 1.49 1.49 1.49 0.95 0.95 0.95 -0.02 1.44 1.48 1.49 1.49 0.95 0.95 0.96 -0.03 1.47 1.48 1.49 1.49 0.95 0.95 0.95
τˆ ∗interact -0.06 1.49 1.49 0.70 0.70 0.95 0.65 0.65 -0.00 1.44 1.48 0.70 0.70 0.96 0.65 0.65 -0.01 1.47 1.48 0.70 0.70 0.95 0.67 0.67
Note: SD, standard deviation; SE, standard error; CP, coverage probability; HW, the
Huber–White variance estimator; NEW: the proposed non-parametric variance estimator.
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Table 7: Simulated biases, standard deviations, standard errors, and coverage probabilities for dif-
ferent estimators and randomization methods under unequal allocation (pi = 2/3)
Stratified Biased-Coin Design Stratified Wei’s Urn Design Hu and Hu’s Randomization
Bias SD SE CP Bias SD SE CP Bias SD SE CP
Model Estimator NEW OLS HW NEW OLS HW NEW OLS HW NEW OLS HW NEW OLS HW NEW OLS HW
1 τˆ -0.03 0.91 0.88 1.07 1.06 0.94 0.98 0.98 -0.03 0.91 0.95 1.07 1.07 0.96 0.98 0.98 -0.02 0.88 0.87 1.08 1.07 0.95 0.98 0.98
τˆadj -0.01 0.89 0.88 0.88 0.87 0.95 0.95 0.95 -0.04 0.83 0.87 0.89 0.87 0.96 0.96 0.96 -0.00 0.88 0.87 0.89 0.88 0.95 0.96 0.96
τˆinteract -0.01 0.89 0.88 0.88 0.86 0.95 0.95 0.94 -0.04 0.83 0.87 0.89 0.87 0.96 0.96 0.95 -0.00 0.88 0.87 0.89 0.87 0.95 0.96 0.95
τˆ ∗ -0.03 0.44 0.42 0.75 0.74 0.93 1.00 1.00 0.02 0.54 0.56 0.75 0.74 0.96 0.99 0.99 -0.02 0.45 0.42 0.75 0.74 0.93 1.00 1.00
τˆ ∗adj -0.01 0.40 0.42 0.43 0.42 0.96 0.97 0.96 0.01 0.42 0.42 0.43 0.42 0.95 0.96 0.95 -0.00 0.43 0.42 0.44 0.42 0.94 0.95 0.94
τˆ ∗interact -0.01 0.40 0.42 0.43 0.41 0.96 0.97 0.96 0.01 0.42 0.42 0.44 0.41 0.95 0.96 0.95 -0.00 0.43 0.42 0.44 0.42 0.94 0.95 0.93
2 τˆ -0.15 0.91 0.88 1.29 1.05 0.94 0.99 0.98 -0.03 0.91 0.95 1.30 1.06 0.96 0.99 0.98 -0.05 0.91 0.88 1.30 1.06 0.95 1.00 0.98
τˆadj 0.03 0.89 0.88 0.82 1.01 0.95 0.93 0.97 0.05 0.91 0.94 0.82 1.02 0.96 0.92 0.97 -0.00 0.91 0.88 0.82 1.02 0.94 0.92 0.97
τˆinteract -0.01 0.89 0.88 0.36 0.49 0.96 0.56 0.71 0.03 0.86 0.89 0.36 0.49 0.95 0.58 0.74 -0.00 0.89 0.88 0.36 0.49 0.95 0.57 0.72
τˆ ∗ -0.11 0.89 0.86 1.27 1.00 0.94 1.00 0.98 -0.01 0.87 0.92 1.28 1.01 0.96 0.99 0.97 -0.04 0.88 0.86 1.28 1.01 0.95 1.00 0.98
τˆ ∗adj 0.05 0.87 0.86 0.81 0.99 0.95 0.93 0.98 0.06 0.88 0.92 0.81 1.00 0.96 0.93 0.98 0.01 0.89 0.86 0.81 1.00 0.95 0.93 0.97
τˆ ∗interact -0.01 0.86 0.86 0.31 0.42 0.95 0.50 0.65 0.03 0.82 0.86 0.31 0.42 0.96 0.53 0.69 0.00 0.86 0.86 0.31 0.43 0.95 0.52 0.66
3 τˆ -0.00 1.76 1.75 2.38 1.80 0.95 0.99 0.96 0.01 1.80 1.77 2.39 1.80 0.95 0.99 0.95 -0.01 1.78 1.75 2.39 1.80 0.95 0.99 0.96
τˆadj -0.00 1.76 1.75 2.27 1.85 0.95 0.99 0.97 0.03 1.82 1.79 2.28 1.85 0.95 0.98 0.96 -0.00 1.77 1.75 2.28 1.85 0.95 0.98 0.96
τˆinteract 0.05 1.76 1.75 2.13 1.56 0.95 0.98 0.92 0.04 1.79 1.76 2.14 1.56 0.94 0.98 0.91 0.02 1.77 1.75 2.13 1.55 0.94 0.98 0.93
τˆ ∗ -0.01 1.62 1.62 1.71 1.63 0.94 0.96 0.95 -0.09 1.61 1.63 1.71 1.64 0.96 0.96 0.96 0.04 1.62 1.62 1.71 1.64 0.94 0.96 0.95
τˆ ∗adj -0.04 1.62 1.62 1.56 1.71 0.95 0.94 0.96 -0.08 1.65 1.66 1.57 1.72 0.95 0.94 0.96 0.03 1.63 1.62 1.56 1.71 0.95 0.93 0.96
τˆ ∗interact 0.05 1.45 1.45 0.84 0.62 0.95 0.73 0.59 -0.01 1.45 1.45 0.85 0.62 0.95 0.76 0.62 0.06 1.46 1.45 0.84 0.61 0.94 0.76 0.59
Note: SD, standard deviation; SE, standard error; CP, coverage probability; HW, the
Huber–White variance estimator; NEW: the proposed non-parametric variance estimator.
C. Synthetic Data of Nefazodone CBASP Trial
To generate the synthetic data, we first fit a non-parametric spline using the function bigssa in
the R package bigspline with six selected covariates: AGE, HAMD17, HAMD24, HAMD COGIN,
Mstatus2 and TreatPD, which are detailed in Table 8. The fitted model can be loaded from the file
spline.RData.
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Table 8: Description of selected covariates
Variable Description
AGE Age of patients in years
HAMD17 Total HAMD-17 score
HAMD24 Total HAMD-24 score
HAMD COGIN HAMD cognitive disturbance score
Mstatus2 Marriage status: 1 if married or living with someone and 0 otherwise
TreatPD Treated past depression: 1 yes and 0 no
Note: HAMD, Hamilton Rating Scale for Depression.
Then, we implement simple randomization and stratified block randomization to obtain the treat-
ment assignments for both the equal (pi = 1/2) and unequal (pi = 2/3) allocations. Among the six
covariates, we use the stratified HAMD17 and Mstatus2 in stratified block randomization, where
the stratified HAMD17 is determined by the relative values of 18 and 21. Once the treatment as-
signments are produced, we generate patient outcomes through the fitted model. For data analysis,
AGE, HAMD24, HAMD COGIN, and TreatPD are used as the additional covariates.
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